Pleural effusion

J10_PLEUREFFUSION

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 J90, J91*
  • Hospital discharge: ICD-9 5111
  • Hospital discharge: ICD-8 511[1-2]
  • Cause of death: ICD-10 J90, J91*
  • Cause of death: ICD-9 5111
  • Cause of death: ICD-8 511[1-2]

2 out of 7 registries used, show all original rules.

6324

4. Check minimum number of events

None

6324

5. Include endpoints

None

6324

6. Filter based on genotype QC (FinnGen only)

6324

Control definitions (FinnGen only)

Control exclude
J10_PLEURA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 49386 19428 29194
Only index persons 36664 14739 21925
Unadjusted period prevalence (%)
Whole population 0.71 0.56 0.82
Only index persons 0.72 0.54 0.84
Median age at first event (years)
Whole population 69.96 71.18 69.13
Only index persons 69.58 70.70 68.83

-FinnGen-

Key figures

All Female Male
Number of individuals 6324 2176 4148
Unadjusted period prevalence (%) 1.45 0.74 1.83
Median age at first event (years) 69.04 66.29 70.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
5662
Matched controls
56620
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.4
323.0
3523
18623
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.6
323.0
2610
10871
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
35.5
323.0
1388
513
GAC00
NOMESCO Finland
Biopsy of pleura
298.8
323.0
336
12
TGA30
NOMESCO Finland
Thoracocentesis
165.6
323.0
620
42
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
5.3
323.0
1394
3265
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
46.7
323.0
819
204
J94.8
ICD-10 Finland
Other specified pleural conditions
1246.3
323.0
938
9
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.7
323.0
849
1263
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4503599627370496.0
323.0
5348
20
C03CA01
ATC
furosemide; systemic
3.2
323.0
3007
14704
R06.0
ICD-10 Finland
Dyspnoea
3.4
323.0
2204
8989
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
28.9
323.0
869
353
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.4
323.0
1253
2424
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
33.1
308.1
410
133
J94.9
ICD-10 Finland
Pleural condition, unspecified
1593.7
306.7
296
*
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
155.5
266.4
281
19
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
20.4
254.5
390
205
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.2
239.2
1514
5734
H02AB06
ATC
prednisolone; systemic
2.5
235.8
3133
18646
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
599.7
234.5
231
*
I50.9
ICD-10 Finland
Heart failure, unspecified
3.1
231.9
1592
6364
J96.1
ICD-10 Finland
Chronic respiratory failure
372.9
216.6
217
6
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.0
215.8
988
2861
Z51.5
ICD-10 Finland
Palliative care
4.6
213.2
812
1972
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
102.3
205.8
226
23
N02AA05
ATC
oxycodone; systemic
3.0
204.8
1435
5742
JN4BD
NOMESCO Finland
Extensive body CT
3.4
197.4
1120
3842
C45.0
ICD-10 Finland
Mesothelioma of pleura
141.0
191.7
204
15
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
65.6
190.0
221
35
J01MA14
ATC
moxifloxacin; systemic
3.9
188.2
866
2496
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.3
187.2
772
2012
GD1AD
NOMESCO Finland
Thorax CT examination
5.9
184.9
555
1023
J01MA12
ATC
levofloxacin; systemic
2.6
175.6
1563
7147
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
816.1
162.4
159
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
73.3
161.7
185
26
J86.9
ICD-10 Finland
Pyothorax without fistula
19.1
159.6
249
136
H02AB02
ATC
dexamethasone; systemic
3.3
156.9
884
2969
A03FA01
ATC
metoclopramide; systemic, rectal
2.5
156.4
1463
6807
130
Kela drug reimbursment
Malignant tumour
3.3
156.1
906
3111
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
8.3
154.2
358
456
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.9
151.5
1062
4147
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.1
137.0
877
3205
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
136.5
1021
4125
I50.0
ICD-10 Finland
Congestive heart failure
3.1
135.2
850
3065
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
4.8
133.1
473
1046
A04AA01
ATC
ondansetron; systemic, rectal
3.8
127.5
584
1645
JN4AD
NOMESCO Finland
Body CT examination
3.3
123.4
702
2348
A02BC02
ATC
pantoprazole; systemic
2.0
122.2
3720
27962
J92.9
ICD-10 Finland
Pleural plaque without asbestos
162.3
120.8
127
8
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.5
120.4
458
1084
C03DA01
ATC
spironolactone; oral
2.7
118.7
944
3926
R03BB04
ATC
tiotropium bromide; inhalant
2.7
114.8
886
3616
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.6
113.9
427
994
J96.0
ICD-10 Finland
Acute respiratory failure
553.5
110.2
109
*
51120
ICD-8 Finland
Pleurisy, Other specified forms of effusion, except tuberculous
+∞
105.5
101
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
103.3
938
4174
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
99.7
1392
7591
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.2
98.4
1254
6571
J98.1
ICD-10 Finland
Pulmonary collapse
205.5
97.7
101
5
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.9
96.0
1906
11898
B01AA03
ATC
warfarin; systemic
1.9
95.1
1732
10465
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.4
93.5
362
867
R03AC02
ATC
salbutamol; inhalant
1.8
92.2
2654
18717
ZX120
NOMESCO Finland
Intravenous
2.7
89.7
708
2895
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.5
89.6
453
1371
C07AB07
ATC
bisoprolol; oral
1.7
86.9
3082
23023
ZXD05
NOMESCO Finland
Urgent procedure
1.9
86.5
1852
11765
R50.9
ICD-10 Finland
Fever, unspecified
2.3
86.4
939
4539
R18
ICD-10 Finland
Ascites
6.5
86.1
234
373
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
9.5
86.0
182
197
WF049
NOMESCO Finland
Radiotherapy of metastasis
4.1
83.2
349
900
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.9
83.1
1441
8464
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
83.1
1896
12268
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.0
83.1
1282
7203
GAA31
NOMESCO Finland
Thoracoscopy
32.0
82.7
110
35
L01CA04
ATC
vinorelbine; systemic
13.4
81.4
145
111
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
408.2
81.1
81
*
9050/3-C38.4
ICD-O-3
Mesothelioma, malignant of pleura, NOS
111.7
81.1
88
8
J93.9
ICD-10 Finland
Pneumothorax, unspecified
278.4
80.7
82
*
TGC00
NOMESCO Finland
Bronchial lavation
5.1
80.4
268
548
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.4
79.6
422
1322
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
76.9
1184
6618
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
3.9
76.1
335
901
J93.8
ICD-10 Finland
Other pneumothorax
748.0
75.4
74
*
R02
ICPC
Shortness of breath/dyspnoea
2.3
75.4
787
3709
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.0
74.8
480
1719
B01AB05
ATC
enoxaparin; parenteral
1.8
74.7
1816
11892
A04AA02
ATC
granisetron; systemic, transdermal
3.1
72.8
440
1512
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.6
72.8
265
595
9052/3-C38.4
ICD-O-3
Epithelioid mesothelioma, malignant of pleura, NOS
351.4
69.7
70
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
69.7
1719
11255
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
68.7
2440
17745
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.9
68.5
448
1621
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
3.1
68.3
401
1350
J01FF01
ATC
clindamycin; systemic
1.8
67.7
1486
9354
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
67.7
1711
11261
P01BA02
ATC
hydroxychloroquine; oral
2.7
67.4
494
1919
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.3
66.6
682
3170
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
66.5
1505
9560
WW500
NOMESCO Finland
Blood transfusion
3.3
65.9
352
1106
5119X
ICD-9 Finland
Pleurisy, Unspecified pleural effusion
+∞
65.7
63
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.9
65.0
417
1489
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
12.3
64.4
119
99
WZC30
NOMESCO Finland
Teaching
2.1
62.3
804
4144
J94.2
ICD-10 Finland
Haemothorax
164.3
62.1
65
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
61.0
1025
5857
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.0
60.9
840
4448
WX892
NOMESCO Finland
Monitored bed care
2.5
60.6
540
2334
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.4
59.6
537
2336
TGA10
NOMESCO Finland
Needle biopsy of pleura
+∞
59.5
57
*
TK800
NOMESCO Finland
Hemodialysis
4.6
59.5
214
475
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
6.3
58.7
161
260
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
58.3
539
2373
B01AB10
ATC
tinzaparin; parenteral
2.6
58.1
472
1941
I50.1
ICD-10 Finland
Left ventricular failure
2.6
57.6
447
1792
J01DB01
ATC
cefalexin; oral
1.6
57.4
4187
35913
XG410
NOMESCO Finland
Flow-volume spirometry
3.4
56.8
298
923
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.2
56.6
228
565
L03AA13
ATC
pegfilgrastim; parenteral
3.5
56.4
276
809
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
45.1
54.5
67
15
N02AX02
ATC
tramadol; systemic, rectal
1.6
54.1
2354
17668
JN4CD
NOMESCO Finland
Very extensive body CT
3.1
53.4
320
1090
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.8
53.2
377
1429
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
3.5
52.5
259
764
GAC46
NOMESCO Finland
Partial decortication of pleura
61.6
52.4
61
10
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
6.9
51.9
133
196
128
Kela drug reimbursment
Cancers of female genital organs
6.2
50.7
140
229
J45.9
ICD-10 Finland
Asthma, unspecified
1.8
50.2
924
5410
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.1
50.1
657
3391
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
7.9
50.0
117
151
R82
ICPC
Pleurisy/pleural effusion
92.6
49.9
55
6
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
7.2
49.4
123
174
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.3
49.2
496
2275
ZXE00
NOMESCO Finland
One hour or less
1.6
48.4
2043
15099
C01AA05
ATC
digoxin; systemic
2.0
48.1
726
3953
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
5.3
47.8
151
291
A07EC01
ATC
sulfasalazine; oral, rectal
2.3
46.8
460
2084
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.8
46.3
325
1224
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.7
46.0
211
587
I50
ICD-10 Finland
Heart failure
2.9
45.4
289
1023
L03AA02
ATC
filgrastim; parenteral
3.6
45.4
211
594
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
2.3
44.9
465
2158
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
9.8
44.9
92
95
5111B
ICD-9 Finland
Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA ALIA DEFINITA]
+∞
44.8
43
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.6
44.6
343
1363
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.7
44.1
1028
6463
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
43.9
644
3460
WF004
NOMESCO Finland
Palliative radiotherapy
3.9
43.8
188
494
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
9.6
43.4
90
95
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
43.1
294
1088
R84
ICPC
Malignant neoplasm bronchus/lung
12.3
42.7
78
64
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
42.6
1941
14484
J01CA04
ATC
amoxicillin; systemic
1.5
42.4
3888
33615
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
42.2
621
3342
D64.9
ICD-10 Finland
Anaemia, unspecified
1.9
42.1
727
4143
192
Kela drug reimbursment
Fulvestrant
14.7
41.5
70
48
H02AB07
ATC
prednisone; oral
1.8
41.5
791
4661
R4110
NOMESCO Finland
Physiotherapy
1.6
41.3
1389
9630
N02BE01
ATC
paracetamol; systemic, rectal
1.6
41.2
4495
40251
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
9.7
40.7
84
88
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.4
40.6
152
352
M04AA01
ATC
allopurinol; systemic
1.7
40.6
951
5975
L02BA03
ATC
fulvestrant; parenteral
13.9
40.5
70
51
XG466
NOMESCO Finland
Sleep oxymetry
3.3
40.4
215
673
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.2
40.2
427
1999
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
5.1
40.1
131
263
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.7
40.1
119
214
B03XA02
ATC
darbepoetin alfa; parenteral
3.8
40.0
175
468
N05CF01
ATC
zopiclone; oral
1.5
39.9
1798
13332
207
Kela drug reimbursment
Chronic arrhythmias
1.7
39.8
1018
6553
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
27.2
39.4
54
20
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.6
39.2
1420
10005
R4190
NOMESCO Finland
Nutritional therapy
3.6
38.6
184
529
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.9
38.5
248
885
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.4
38.2
193
581
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
4.3
37.8
145
344
GAC37
NOMESCO Finland
Endoscopic chemical pleurodesis
+∞
37.5
36
*
XX3DW
NOMESCO Finland
Time consuming IT work
1.9
37.4
582
3189
A46
ICD-10 Finland
Erysipelas
1.7
37.3
855
5321
Z2446
NOMESCO Finland
Social worker
2.3
36.8
346
1530
XGX10
NOMESCO Finland
Intrapleural ultrasonography
100.7
36.7
40
*
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
9.8
36.3
74
76
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.4
36.2
311
1313
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
11.1
36.0
69
63
GAC30
NOMESCO Finland
Artificial pneumothorax
359.5
36.0
36
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
35.5
241
890
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
5.9
35.2
101
175
N03AX16
ATC
pregabalin; oral
1.6
35.1
1148
7855
L04AX01
ATC
azathioprine; systemic
2.8
35.0
229
826
1BA04
NOMESCO Finland
NA
34.9
34.9
45
13
A04AA55
ATC
palonosetron, combinations; systemic
3.8
34.9
153
411
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.1
34.8
202
674
I30.9
ICD-10 Finland
Acute pericarditis, unspecified
9.2
34.6
73
80
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
14.2
34.6
59
42
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.1
34.4
193
628
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
34.2
1616
12012
N18.8
ICD-10 Finland
Other chronic renal failure
2.8
34.1
228
833
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.2
34.0
385
1856
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.2
33.4
186
603
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
4.4
33.3
125
291
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
56.1
33.2
39
7
ZXE20
NOMESCO Finland
More than three and less than five hours
1.7
33.2
786
4927
A06AH03
ATC
naloxegol; oral
5.2
33.1
104
201
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
33.1
878
5681
A28
ICPC
Limited function/disability NOS
1.6
33.0
962
6380
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
6.5
32.8
87
136
M05.9
ICD-10 Finland
Seropositive rheumatoid arthritis, unspecified
3.4
32.5
161
478
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
10.4
32.5
64
62
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.2
32.3
346
1627
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.2
32.0
124
298
A16.5
ICD-10 Finland
Tuberculous pleurisy, without mention of bacteriological or histological confirmation
88.1
31.7
35
*
A15.6
ICD-10 Finland
Tuberculous pleurisy, confirmed bacteriologically and histologically
114.0
31.7
34
*
R04.2
ICD-10 Finland
Haemoptysis
2.6
31.5
244
974
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.3
31.2
305
1372
GAC43
NOMESCO Finland
Total decortication of pleura
160.8
30.7
32
*
SPAT1254
SPAT
Administration of medicine
1.6
30.5
815
5272
1501
Kela drug reimbursment
Palbociclib
11.5
30.5
57
50
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
3.9
30.4
130
342
J01FA06
ATC
roxithromycin; oral
1.4
30.3
1914
14982
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
6.1
30.3
84
140
GAC36
NOMESCO Finland
Chemical pleurodesis
+∞
30.2
29
*
J96.9
ICD-10 Finland
Respiratory failure, unspecified
38.3
30.2
38
10
L04AA06
ATC
mycophenolic acid; systemic
4.4
30.1
111
255
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
30.0
315
1467
N02AA01
ATC
morphine; systemic, rectal
3.8
29.6
128
341
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
3.5
29.5
142
413
JN3AD
NOMESCO Finland
Abdominal CT examination
2.0
29.5
418
2207
A02BC01
ATC
omeprazole; systemic
1.5
29.3
1473
11019
R95
ICPC
Chron obstructive pulmonary disease
2.8
29.3
191
688
C09AA05
ATC
ramipril; oral
1.4
29.3
1522
11459
L28
ICPC
Limited function/disability (L)
1.6
29.2
896
6004
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.0
29.1
119
302
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
29.0
438
2368
L02BA01
ATC
tamoxifen; oral
2.9
28.7
182
643
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.6
28.6
807
5291
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
28.6
680
4254
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.1
28.5
112
274
J01AA02
ATC
doxycycline; systemic
1.4
28.4
3917
34922
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
4.2
28.4
109
261
N18.0
ICD-10 Finland
End-stage renal disease
3.9
28.4
118
304
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
28.3
372
1906
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
3.2
28.1
152
483
J94.0
ICD-10 Finland
Chylous effusion
+∞
28.1
27
*
5111A
ICD-9 Finland
Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA BACTERICA]
+∞
28.1
27
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.5
28.0
224
908
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
2.2
28.0
289
1334
A11CC03
ATC
alfacalcidol; systemic
3.0
27.9
168
576
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
8.4
27.6
61
73
TGW99
NOMESCO Finland
Other minor procedure in thoracic surgery
15.6
27.6
45
29
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
47.4
27.4
33
7
AA1AD
NOMESCO Finland
CT of head and brain
1.5
27.4
1324
9805
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.8
27.3
187
694
XF600
NOMESCO Finland
Bloodpressure measurement
2.0
27.2
361
1854
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
5.2
27.2
85
164
A04AD12
ATC
aprepitant; systemic
3.8
27.2
119
321
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.8
27.1
116
307
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
12.0
26.9
49
41
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.0
26.7
355
1824
J98.6
ICD-10 Finland
Disorders of diaphragm
272.3
26.7
27
*
394
Kela drug reimbursment
Palbociclib
10.9
26.7
51
47
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.1
26.5
305
1477
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
2.4
26.5
225
945
K77
ICPC
Heart failure
2.9
26.4
164
574
A06AD11
ATC
lactulose; oral
1.5
26.3
916
6310
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
16.3
26.2
42
26
B01AB04
ATC
dalteparin; parenteral
2.1
26.2
293
1402
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.2
26.1
102
249
Z3226
NOMESCO Finland
Physiotherapist
1.5
26.0
914
6308
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.7
26.0
183
691
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
25.9
903
6220
WX872
NOMESCO Finland
Intensive care
2.1
25.8
307
1508
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
3.8
25.8
113
305
JAL30
NOMESCO Finland
Omentectomy
5.4
25.7
78
146
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
10.1
25.6
51
51
155
Kela drug reimbursment
Afatinib and gefitinib
24.1
25.6
36
15
AN1
HP
Coronary angiography
1.6
25.6
784
5236
R81
ICPC
Pneumonia
2.6
25.5
197
786
M06.9
ICD-10 Finland
Rheumatoid arthritis, unspecified
2.7
25.5
178
671
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.3
25.2
247
1115
M05BX04
ATC
denosumab; parenteral
2.2
25.1
279
1332
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.2
25.1
271
1276
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.3
25.1
232
1016
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.9
24.9
381
2068
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.0
24.8
149
510
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.0
24.8
352
1856
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
24.6
1933
15565
L02BG04
ATC
letrozole; oral
2.3
24.5
238
1069
XW000
NOMESCO Finland
Bone marrow biopsy
2.2
24.5
257
1196
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
5.2
24.2
76
148
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
24.1
766
5156
Z3231
NOMESCO Finland
Registered nurse
1.4
24.0
1402
10720
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
4.4
23.8
88
204
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
6.4
23.7
63
100
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2.9
23.7
150
532
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
4.0
23.6
97
248
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
23.6
1370
10455
HA1AA
NOMESCO Finland
X-ray mammography
2.1
23.6
280
1377
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
4.5
23.5
84
188
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.8
23.5
79
166
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
2.9
23.5
149
530
115
Kela drug reimbursment
Breast cancer
2.0
23.5
315
1625
R05
ICD-10 Finland
Cough
1.5
23.4
876
6116
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
23.2
2091
17171
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
23.2
831
5748
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.3
23.1
212
928
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.6
23.0
105
294
J45.1
ICD-10 Finland
Nonallergic asthma
1.9
22.9
328
1736
C56
ICD-10 Finland
Malignant neoplasm of ovary
9.1
22.9
48
53
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
13.0
22.8
40
31
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.0
22.8
308
1592
C01DA14
ATC
isosorbide mononitrate; oral
1.4
22.6
1127
8347
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
5.2
22.6
71
139
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.8
22.5
432
2528
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.8
22.4
392
2228
I25.2
ICD-10 Finland
Old myocardial infarction
1.7
22.2
531
3318
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.5
22.2
745
5073
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
3.7
22.1
97
264
N05BA04
ATC
oxazepam; oral
1.4
22.0
1128
8396
Z2221
NOMESCO Finland
Medical doctor
1.4
22.0
1306
9986
L01XE33
ATC
[U] palbociclib; oral
11.1
21.8
41
37
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.0
21.8
282
1437
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2.6
21.8
158
609
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
3.6
21.6
97
269
GAC10
NOMESCO Finland
Removal of foreign body from pleural cavity
115.4
21.6
23
*
L01BC06
ATC
capecitabine; oral
2.3
21.6
212
959
L04AA13
ATC
leflunomide; oral
2.9
21.6
135
475
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.1
21.5
250
1219
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.0
21.3
123
411
K78
ICPC
Atrial fibrillation/flutter
1.7
21.2
513
3210
L88
ICPC
Rheumatoid/seropositive arthritis
2.4
21.2
190
821
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
5.8
21.2
60
104
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
4.6
21.2
74
163
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.6
21.1
585
3796
C45.9
ICD-10 Finland
Mesothelioma, unspecified
50.2
21.1
25
5
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.0
21.0
292
1528
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
6.8
21.0
53
79
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
7.1
21.0
51
72
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.1
21.0
115
372
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.5
21.0
884
6324
SPAT1255
SPAT
Intravenous administration of medicine
1.8
20.7
359
2032
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
77.1
20.7
23
*
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
12.9
20.6
36
28
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.4
20.6
100
296
TJA10
NOMESCO Finland
Laparocentesis
10.3
20.5
40
39
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
20.5
352
1985
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
20.5
314
1701
L03AA14
ATC
lipegfilgrastim; parenteral
3.4
20.5
102
307
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.9
20.4
311
1683
R53
ICD-10 Finland
Malaise and fatigue
1.4
20.4
990
7281
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
4.5
20.3
72
161
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.9
20.2
128
455
GAC47
NOMESCO Finland
Endoscopic partial decortication of pleura
32.6
20.2
26
8
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
2.7
20.2
144
550
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.1
20.1
242
1195
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.8
20.1
386
2262
TK810
NOMESCO Finland
Hemofiltration
5.4
20.0
60
112
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.1
19.7
230
1122
SPAT1056
SPAT
Pleural puncture
73.7
19.7
22
*
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.7
19.6
416
2507
TFP20
NOMESCO Finland
Cardiodefibrillation
1.7
19.6
454
2807
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
7.0
19.6
48
69
A79
ICPC
Malignancy NOS
3.3
19.6
100
308
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
2.3
19.5
190
855
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.6
19.5
553
3606
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.7
19.5
140
535
SPAT1062
SPAT
Lung clearance therapy
7.7
19.5
45
59
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.0
19.4
114
387
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
6.5
19.4
50
77
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
19.4
961
7085
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
19.3
500
3187
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.8
19.1
335
1905
SPAT1263
SPAT
Sampling
1.3
19.1
1986
16521
C01BD01
ATC
amiodarone; systemic
2.2
19.0
194
891
R09.1
ICD-10 Finland
Pleurisy
3.4
18.9
91
268
SPAT1262
SPAT
Handing over of treatment supplies
1.4
18.8
956
7077
WX725
NOMESCO Finland
Noninvasive ventilation
2.1
18.8
208
994
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.5
18.8
89
259
JAH01
NOMESCO Finland
Laparoscopy
2.3
18.7
174
767
J01DA01
ATC
[U] cefalexin; systemic
1.3
18.6
3001
26448
JAH00
NOMESCO Finland
Laparotomy
2.4
18.6
162
693
127
Kela drug reimbursment
Transplant complication
3.6
18.5
84
236
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
2.8
18.3
121
442
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
18.2
1446
11538
S97
ICPC
Chronic ulcer skin
1.8
18.1
314
1779
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
4.6
18.1
62
135
H02AB04
ATC
methylprednisolone; systemic
1.5
18.0
655
4533
201
Kela drug reimbursment
Chronic cardiac insufficiency
1.7
17.9
357
2116
TGD00
NOMESCO Finland
Needle biopsy of lung
5.8
17.7
50
87
WX002
NOMESCO Finland
Sedation and analgesia
1.4
17.7
949
7089
L02BG06
ATC
exemestane; oral
4.0
17.7
71
180
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
17.6
1491
11999
L01EF01
ATC
palbociclib; oral
12.5
17.6
31
25
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.9
17.5
256
1366
A12AA04
ATC
calcium carbonate; oral
2.9
17.5
109
386
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
17.5
387
2365
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
3.0
17.4
101
341
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.6
17.3
494
3226
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.9
17.3
246
1300
C07AB02
ATC
metoprolol; systemic
1.3
17.2
1260
9914
A10AE05
ATC
insulin detemir; parenteral
1.9
17.2
277
1528
J43.9
ICD-10 Finland
Emphysema, unspecified
3.0
17.2
101
344
R03BA05
ATC
fluticasone; inhalant
1.5
17.2
720
5125
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
2.1
17.2
198
963
E0000UV
ATC
NA
1.3
17.2
1698
13969
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.6
17.1
127
499
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.0
17.1
231
1199
A07AA09
ATC
vancomycin; oral
3.3
17.1
86
263
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.7
17.0
349
2085
I97.0
ICD-10 Finland
Postcardiotomy syndrome
5.8
17.0
48
84
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
4.7
16.9
57
122
J47
ICD-10 Finland
Bronchiectasis
2.9
16.9
105
371
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
3.6
16.9
76
213
GAA97
NOMESCO Finland
Other thoracoscopic drainage procedures on pleura
19.3
16.8
25
13
I27.2
ICD-10 Finland
Other secondary pulmonary hypertension
7.0
16.8
41
59
C56.98
ICD-10 Finland
Malignant tumor of the ovary, indeterminate histology
12.1
16.8
30
25
ZXA00
NOMESCO Finland
Right side
1.3
16.7
1378
11038
9053/3-C38.4
ICD-O-3
Mesothelioma, biphasic, malignant of pleura, NOS
+∞
16.7
16
*
R85
ICPC
Malignant neopl respiratory other
15.1
16.6
27
18
R06.2
ICD-10 Finland
Wheezing
2.1
16.5
181
863
R28
ICPC
Limited function/disability (R)
3.5
16.5
78
228
81
HP
Angiography of the heart and coronary arteries
1.6
16.4
474
3106
C08CA01
ATC
amlodipine; oral
1.3
16.4
1952
16442
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
2.3
16.4
155
691
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.3
16.3
154
685
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.4
16.2
749
5435
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
3.0
16.2
91
302
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
2.0
16.2
204
1030
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.9
16.1
65
166
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
3.8
16.1
68
181
L01XE13
ATC
[U] afatinib; oral
30.1
16.1
21
7
TKC20
NOMESCO Finland
Catheterisation of bladder
1.6
16.0
416
2655
I48.1
ICD-10 Finland
Persistent atrial fibrillation
2.2
16.0
166
773
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
4.3
16.0
59
139
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.0
16.0
207
1058
GAC96
NOMESCO Finland
Other operation on pleura
21.0
15.9
23
11
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
7.4
15.9
37
50
R11
ICD-10 Finland
Nausea and vomiting
1.7
15.8
348
2120
N17.8
ICD-10 Finland
Other acute renal failure
3.3
15.8
79
241
M13.9
ICD-10 Finland
Arthritis, unspecified
1.7
15.8
310
1826
J45.8
ICD-10 Finland
Mixed asthma
2.3
15.8
144
632
WW200
NOMESCO Finland
Immunization
2.4
15.8
137
585
9051/3-C38.4
ICD-O-3
Fibrous mesothelioma, malignant of pleura, NOS
60.1
15.7
18
*
V03AE01
ATC
polystyrene sulfonate; oral
2.9
15.7
93
319
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.4
15.7
842
6277
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.6
15.7
430
2780
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
3.0
15.7
92
314
51110
ICD-8 Finland
Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis
+∞
15.6
15
*
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
2.2
15.6
165
772
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.5
15.6
492
3292
N06AX11
ATC
mirtazapine; oral
1.3
15.6
1348
10849
3004
Kela drug reimbursment
Osimertinib
26.3
15.6
21
8
R60.0
ICD-10 Finland
Localized oedema
1.5
15.6
558
3844
GD1UN
NOMESCO Finland
Lung circulation SPECT
4.8
15.5
51
107
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
1.8
15.5
275
1572
C50.99
ICD-10 Finland
Breast, unspecified
2.6
15.4
112
436
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
2.4
15.4
128
534
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
3.8
15.3
65
174
XG460
NOMESCO Finland
Short time oxymetry
2.6
15.3
111
430
I10
ICD-10 Finland
Essential (primary) hypertension
1.3
15.2
3224
29041
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
3.7
15.2
67
185
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
4.5
15.2
53
118
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
15.1
681
4911
R05
ICPC
Cough
1.4
15.1
882
6673
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.9
15.1
225
1212
A41.8
ICD-10 Finland
Other specified sepsis
2.6
15.0
109
422
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.8
15.0
266
1519
GD2SN
NOMESCO Finland
Lung ventilation SPECT
4.4
15.0
53
120
UJF32
NOMESCO Finland
Coloscopy
1.3
15.0
1264
10130
WX722
NOMESCO Finland
PEEP
1.9
14.9
231
1258
WX402
NOMESCO Finland
General anaesthesia
1.5
14.9
634
4522
WX730
NOMESCO Finland
Conventional respirator
2.9
14.9
92
324
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.6
14.9
112
443
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
5.9
14.9
41
70
A02BC05
ATC
esomeprazole; systemic
1.3
14.7
1818
15333
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
4.7
14.6
49
105
N05BA06
ATC
lorazepam; systemic, sublingual
1.8
14.6
258
1471
J93.0
ICD-10 Finland
Spontaneous tension pneumothorax
+∞
14.6
14
*
5110B
ICD-9 Finland
Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]
+∞
14.6
14
*
FEB10
NOMESCO Finland
Decompression and drainage of pericardium
7.7
14.6
33
43
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
2.3
14.5
135
598
WX110
NOMESCO Finland
Local anesthesy
1.2
14.5
2948
26355
A12BA01
ATC
potassium chloride; oral
1.7
14.5
302
1813
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
14.5
685
4986
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
2.2
14.5
150
698
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
3.1
14.4
80
264
P01AB01
ATC
metronidazole; oral, rectal
1.3
14.4
1605
13350
Z49.2
ICD-10 Finland
Other dialysis
4.6
14.4
49
107
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
3.9
14.4
58
149
137
Kela drug reimbursment
Uraemia requiring dialysis
3.8
14.4
60
159
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
14.4
139
628
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
1.8
14.3
258
1482
B03BA03
ATC
hydroxocobalamin; parenteral
1.7
14.3
328
2021
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.3
14.3
131
577
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.1
14.3
79
260
Z57.2
ICD-10 Finland
Occupational exposure to dust
11.3
14.2
26
23
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
11.3
14.2
26
23
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
8.2
14.2
31
38
J86.09
ICD-10 Finland
Pyothorax with fistula
19.1
14.2
21
11
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
14.2
407
2659
N19
ICD-10 Finland
Unspecified kidney failure
1.9
14.2
209
1121
J01MA02
ATC
ciprofloxacin; systemic
1.3
14.2
1987
17000
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
2.9
14.2
85
296
R04.0
ICD-10 Finland
Epistaxis
1.6
14.2
399
2597
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
5.7
14.1
40
71
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.6
14.1
102
397
FNC20
NOMESCO Finland
Aorto-coronary venous bypass with two distal anastomoses
2.1
14.1
157
755
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
1.9
14.1
210
1131
L02BG03
ATC
anastrozole; oral
3.1
14.0
78
258
E87.5
ICD-10 Finland
Hyperkalaemia
2.5
14.0
110
447
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
5.3
14.0
42
80
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
1.7
13.9
306
1867
GDC00
NOMESCO Finland
Lobectomy of lung
4.0
13.8
55
140
R07.1
ICD-10 Finland
Chest pain on breathing
3.1
13.8
76
250
01220
ICD-8 Finland
Other respiratory tuberculosis, Pleurisy with effusion without mention of cause
7.8
13.8
31
40
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
4.4
13.8
49
112
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
13.8
361
2307
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
13.7
1459
12047
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
3.7
13.7
59
161
R03AC18
ATC
indacaterol; inhalant
3.7
13.7
58
156
ZX090
NOMESCO Finland
Other technic of radiotherapy
2.1
13.7
147
697
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.3
13.7
68
208
B01AF02
ATC
apixaban; oral
1.5
13.7
532
3726
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.7
13.6
298
1812
J01FA09
ATC
clarithromycin; systemic
1.3
13.6
1177
9449
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
13.6
1514
12576
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
13.6
656
4790
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
3.4
13.6
64
188
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
4.1
13.6
52
128
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
2.8
13.5
88
320
J10.0
ICD-10 Finland
Influenza with pneumonia, seasonal influenza virus identified
3.3
13.5
66
199
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
2.2
13.5
133
606
NHQ40
NOMESCO Finland
Amputation of toe
2.4
13.5
113
475
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
4.4
13.5
48
110
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
4.5
13.4
47
106
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
9.3
13.4
27
29
GDA10
NOMESCO Finland
Biopsy of lung
9.3
13.4
27
29
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
4.4
13.4
48
111
WW200
SPAT
NA
0.5
13.4
134
2451
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.2
13.3
129
584
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
13.3
1289
10504
I31.8
ICD-10 Finland
Other specified diseases of pericardium
11.5
13.3
24
21
HAC20
NOMESCO Finland
Total mastectomy
2.1
13.2
155
762
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
3.1
13.2
72
236
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.6
13.1
58
162
WX882
NOMESCO Finland
High dependency care
2.1
13.1
142
675
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
7.9
13.0
29
37
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
6.2
13.0
34
55
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
13.0
749
5644
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
2.4
12.9
106
440
SPAT1109
SPAT
Analgesia with portable analgesic pump
4.2
12.9
48
115
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
3.7
12.9
55
149
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
8.5
12.7
27
32
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
10.5
12.7
24
23
341
Kela drug reimbursment
Afatinib and gefitinib
32.1
12.6
16
5
B03XA01
ATC
erythropoietin; parenteral
3.3
12.5
63
195
A03
ICPC
Fever
1.5
12.5
482
3372
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
12.5
1407
11684
L01EB04
ATC
osimertinib; oral
24.3
12.4
17
7
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
3.7
12.4
53
144
SPAT1229
SPAT
Assessment of need for aid
1.5
12.4
412
2788
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.3
12.4
45
106
FWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels
3.6
12.4
55
155
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.6
12.4
327
2095
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
2.3
12.3
115
513
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
1.6
12.3
285
1767
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
5.2
12.2
37
72
Z72.0
ICD-10 Finland
Tobacco use
2.4
12.2
103
438
A10AE04
ATC
insulin glargine; parenteral
1.5
12.2
453
3141
GEA00
NOMESCO Finland
Mediastinoscopy
5.7
12.2
34
60
SPAT1269
SPAT
Other puncture and/or drainage
3.9
12.2
49
127
M05BA04
ATC
alendronic acid; oral
1.5
12.1
378
2524
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.0
12.1
162
841
AA1
HP
Conventional CABG
2.0
12.1
149
750
C07AA07
ATC
sotalol; systemic
1.7
12.1
256
1545
Z49.0
ICD-10 Finland
Preparatory care for dialysis
3.2
12.1
61
190
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
12.1
324
2085
ZXA05
NOMESCO Finland
Left side
1.3
12.0
1254
10298
1519
Kela drug reimbursment
NA
21.3
12.0
17
8
JN6AD
NOMESCO Finland
CT of torso and neck
3.1
11.9
64
208
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
2.5
11.9
90
360
I25.5
ICD-10 Finland
Ischaemic cardiomyopathy
2.2
11.9
120
556
191
Kela drug reimbursment
Erlotinib
5.7
11.9
33
58
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.3
11.9
111
495
J13
ICD-10 Finland
Pneumonia due to Streptococcus pneumoniae
3.4
11.9
57
171
GDD20
NOMESCO Finland
Extended pneumonectomy
46.7
11.9
14
*
GAC40
NOMESCO Finland
Pleurodesis with decortication
46.7
11.9
14
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
1.9
11.8
182
993
M10.9
ICD-10 Finland
Gout, unspecified
1.5
11.7
367
2450
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
2.4
11.6
95
397
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
5.3
11.6
34
64
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
2.3
11.6
107
476
WX721
NOMESCO Finland
Oxygen concentrator therapy
22.9
11.5
16
7
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.1
11.5
125
598
A08
ICPC
Swelling
1.8
11.5
196
1109
J01XX08
ATC
linezolid; systemic
4.7
11.5
38
82
J98.5
ICD-10 Finland
Diseases of mediastinum, not elsewhere classified
+∞
11.5
11
*
J99.1*M31.3
ICD-10 Finland
Respiratory disorders in Wegener's granulomatosis
+∞
11.5
11
*
J91, I500
ICD-10 Finland
NA
+∞
11.5
11
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
1.9
11.4
163
868
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
11.4
1637
13957
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
6.7
11.4
28
42
B05DA
ATC
Isotonic solutions
3.9
11.4
46
120
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
11.3
1031
8310
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
3.7
11.3
48
131
FMD10
NOMESCO Finland
Replacement of aortic valve using biological prosthesis
2.3
11.3
105
470
ZX100
NOMESCO Finland
Oral
2.6
11.3
79
304
K92.1
ICD-10 Finland
Melaena
1.6
11.2
290
1849
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
11.2
610
4550
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.2
11.2
114
530
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
4.6
11.2
37
80
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.4
11.1
92
387
XX1AW
NOMESCO Finland
Written report from X-ray examination without contrast peformed elsewhere
5.4
11.1
32
59
A02BC03
ATC
lansoprazole; oral
1.3
11.1
1352
11302
M06.0
ICD-10 Finland
Seronegative rheumatoid arthritis
2.1
11.1
126
614
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.7
11.1
214
1256
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
1.9
11.1
162
869
Z94.0
ICD-10 Finland
Kidney transplant status
3.1
11.1
58
186
R03AK11
ATC
formoterol and fluticasone; inhalant
2.4
11.1
94
399
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.8
11.1
196
1122
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
11.0
1353
11324
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
3.0
11.0
63
213
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.3
11.0
1237
10242
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
43.4
10.9
13
*
SPAT1211
SPAT
Application of soft bandage
1.5
10.8
392
2704
J20
ICD-10 Finland
Acute bronchitis
1.5
10.8
363
2464
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
15.5
10.8
17
11
L04AA01
ATC
[U] ciclosporin; systemic
2.7
10.8
73
276
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.2
10.8
106
485
C57.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of female genital organs
10.6
10.7
20
19
R29
ICPC
Respiratory symptom/complaint other
1.7
10.7
241
1480
11
HP
Coronary artery bypass surgery
1.8
10.7
178
1001
R06AE07
ATC
cetirizine; oral
1.2
10.7
1622
13895
SPAT1104
SPAT
Monitoring of emergency patient
1.6
10.6
301
1966
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
2.0
10.6
127
633
A16.0
ICD-10 Finland
Tuberculosis of lung, bacteriologically and histologically negative
7.5
10.6
24
32
N07BA03
ATC
varenicline; oral
1.9
10.6
150
795
NF1AA
NOMESCO Finland
Hip X-ray examination
1.5
10.6
419
2943
L04AD01
ATC
ciclosporin; systemic
2.6
10.6
75
290
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
2.7
10.6
72
273
8441/3-C56.9
ICD-O-3
Serous carcinoma, NOS, of ovary
8.0
10.6
23
29
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.0
10.5
128
643
XG405
NOMESCO Finland
Education on PEF monitoring
2.7
10.4
67
246
I48.2
ICD-10 Finland
Chronic atrial fibrillation
1.9
10.4
151
810
V03AE02
ATC
sevelamer; oral
4.6
10.4
35
77
51299
ICD-8 Finland
Spontaneous pneumothorax
+∞
10.4
10
*
J99.0*M05.1
ICD-10 Finland
Rheumatoid lung disease
+∞
10.4
10
*
L01XE06
ATC
[U] dasatinib; systemic
+∞
10.4
10
*
FNC10
NOMESCO Finland
Aorto-coronary venous bypass with single distal anastomosis
2.3
10.4
91
397
R03BB01
ATC
ipratropium bromide; inhalant
1.6
10.4
236
1457
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.0
10.4
123
613
J18.1
ICD-10 Finland
Lobar pneumonia, unspecified
2.7
10.3
69
257
XFE00
NOMESCO Finland
Epicardial ultrasonography
1.9
10.3
142
748
S18
ICPC
Laceration/cut
1.2
10.3
1971
17279
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
4.2
10.3
38
92
I34.0
ICD-10 Finland
Mitral (valve) insufficiency
2.4
10.3
84
353
X76
ICPC
Malignant neoplasm breast female
2.7
10.3
69
259
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
10.3
161
888
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
8.8
10.2
21
24
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.9
10.2
41
107
S27.1
ICD-10 Finland
Traumatic haemothorax
3.7
10.2
43
117
71238
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita
3.0
10.2
57
192
N05BA01
ATC
diazepam; systemic, rectal
1.4
10.2
573
4297
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
4.9
10.2
32
66
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
4.3
10.1
36
84
M01CB01
ATC
sodium aurothiomalate; parenteral
2.5
10.1
79
323
A04
ICPC
Weakness/tiredness general
1.4
10.1
554
4131
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.9
10.1
146
781
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.7
10.1
189
1101
N06AB04
ATC
citalopram; systemic
1.3
10.1
866
6915
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
5.9
10.1
27
46
R03AC19
ATC
olodaterol; inhalant
4.7
10.1
33
71
T81.7
ICD-10 Finland
Vascular complications following a procedure, not elsewhere classified
5.6
10.1
28
50
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.2
10.0
1754
15232
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.6
10.0
289
1896
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
1.6
10.0
264
1693
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.7
10.0
209
1262
GDA96
NOMESCO Finland
Other incision, excision of lesion or repair of lung
40.1
10.0
12
*
N05CD07
ATC
temazepam; oral
1.3
9.9
680
5256
R94.2
ICD-10 Finland
Abnormal results of pulmonary function studies
4.2
9.9
36
86
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.9
9.9
132
686
ZX112
NOMESCO Finland
Subcutaneous
2.1
9.9
112
547
TJA40
NOMESCO Finland
Percutaneous local drainage of peritoneal cavity
16.7
9.9
15
9
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
3.1
9.9
52
169
A07AA02
ATC
nystatin; oral
1.6
9.8
276
1800
J18
ICD-10 Finland
Pneumonia, organism unspecified
3.3
9.8
48
148
Z50.0
ICD-10 Finland
Cardiac rehabilitation
2.4
9.8
80
336
R03BA08
ATC
ciclesonide; inhalant
1.6
9.8
265
1713
R77.0
ICD-10 Finland
Abnormality of albumin
8.7
9.8
20
23
R03AC13
ATC
formoterol; inhalant
1.7
9.7
211
1289
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.6
9.6
222
1378
E86
ICD-10 Finland
Volume depletion
1.9
9.6
136
725
TND11
NOMESCO Finland
Injection of diagnostic or therapeutic substance in joint, wrist or hand
2.8
9.6
61
223
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.0
9.5
117
592
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
1.7
9.5
184
1085
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.6
9.5
264
1715
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
2.4
9.5
78
327
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
3.4
9.5
44
130
WX204
NOMESCO Finland
Axillary plexus blockaced
2.0
9.5
123
635
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.1
9.5
49
157
20199
ICD-8 Finland
Hodgkin's disease
15.0
9.5
15
10
N03AG01
ATC
valproic acid; systemic, rectal
1.6
9.5
219
1360
ZX121
NOMESCO Finland
Central venous catheter
5.4
9.5
27
50
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.3
9.4
87
389
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
3.0
9.4
54
183
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
2.2
9.4
87
390
GDD96
NOMESCO Finland
Other pneumonectomy
100.2
9.4
10
*
150
Kela drug reimbursment
Dasatinib
100.2
9.4
10
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
3.3
9.4
46
142
FE2AT
NOMESCO Finland
Pericardial cathetrisation with ultrasound guidance
30.0
9.4
12
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
7.5
9.4
21
28
C45.1
ICD-10 Finland
Mesothelioma of peritoneum
17.5
9.4
14
8
J94.1
ICD-10 Finland
Fibrothorax
+∞
9.4
9
*
C45
ICD-10 Finland
Mesothelioma
+∞
9.4
9
*
RS220
NOMESCO Finland
NA
2.8
9.4
57
204
1510
Kela drug reimbursment
Niraparib
21.7
9.3
13
6
3009
Kela drug reimbursment
Niraparib
21.7
9.3
13
6
R03AK08
ATC
formoterol and beclometasone; inhalant
1.9
9.3
130
690
L01XE03
ATC
[U] erlotinib; oral
5.5
9.3
26
47
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
2.3
9.3
80
346
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
2.4
9.2
74
309
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.5
9.2
268
1760
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.5
9.2
271
1787
K65.0
ICD-10 Finland
Acute peritonitis
2.5
9.2
70
284
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
9.2
268
1765
1CD01
NOMESCO Finland
NA
7.3
9.2
21
29
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
5.4
9.2
26
48
N02AA03
ATC
hydromorphone; systemic, rectal
5.7
9.2
25
44
313
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)
2.2
9.2
90
414
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.8
9.1
140
768
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
3.0
9.1
49
162
ZSF00
NOMESCO Finland
Procedure related to previous procedure classified in chapter F
4.9
9.1
28
57
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
2.1
9.1
94
441
F10.25
ICD-10 Finland
Alcohol dependence continuous use
2.5
9.0
69
281
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
3.4
9.0
41
120
I20.09
ICD-10 Finland
Unstable angina
1.5
9.0
322
2218
196
Kela drug reimbursment
Paricalcitol and cinacalcet
4.4
9.0
31
71
B05DB
ATC
Hypertonic solutions
3.7
9.0
37
100
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.4
9.0
364
2573
N07BB01
ATC
disulfiram; oral
1.8
9.0
146
817
J15.8
ICD-10 Finland
Other bacterial pneumonia
3.1
8.9
46
148
Z94.2
ICD-10 Finland
Lung transplant status
18.6
8.9
13
7
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
2.3
8.9
75
322
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
6.1
8.9
23
38
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
3.9
8.9
35
91
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
5.5
8.9
25
46
XF404
NOMESCO Finland
Ambulatory ECG
1.4
8.8
448
3296
SPAT1216
SPAT
Assessment of functional ability
1.3
8.8
767
6128
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
6.8
8.8
21
31
WX600
NOMESCO Finland
Single shot through catheter
2.7
8.8
57
212
SPAT1060
SPAT
Administration of oxygen
4.0
8.8
33
82
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
2.9
8.8
51
177
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
6.3
8.8
22
35
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
3.0
8.7
50
170
XF622
NOMESCO Finland
Measurement of minute volume of heart
5.3
8.7
25
47
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
2.9
8.7
50
171
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
3.4
8.6
39
114
N05AH03
ATC
olanzapine; systemic
1.7
8.6
180
1088
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
8.5
719
5722
E87.6
ICD-10 Finland
Hypokalaemia
1.9
8.5
125
676
NH3EA
NOMESCO Finland
Feet X-ray examination with load
2.2
8.5
80
361
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
3.2
8.5
43
137
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.5
8.5
295
2020
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
4.9
8.5
26
53
NDG30
NOMESCO Finland
Fusion of wrist, total
4.5
8.4
28
62
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
5.1
8.4
25
49
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.5
8.4
61
241
TPH05
NOMESCO Finland
Open cannulation of peripheral vein
2.8
8.4
51
184
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
2.3
8.4
74
326
K59.09
ICD-10 Finland
Constipation, unspecified
1.5
8.4
276
1868
51109
ICD-8 Finland
Pleurisy, Sicca NUD
+∞
8.3
8
*
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.4
8.3
387
2806
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.1
8.3
42
134
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.9
8.3
48
166
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.0
8.3
98
490
197
Kela drug reimbursment
Sunitinib
4.3
8.3
29
68
R03BB07
ATC
umeclidinium bromide; inhalant
3.2
8.3
41
129
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
3.1
8.3
43
140
J10.1
ICD-10 Finland
Influenza with other respiratory manifestations, seasonal influenza virus identified
2.4
8.3
68
290
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.4
8.2
37
108
R03BA01
ATC
beclometasone; inhalant
1.3
8.2
547
4211
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.2
8.2
1307
11206
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.7
8.2
174
1057
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
5.1
8.1
24
47
TJD20
NOMESCO Finland
Change of gastrostomy tube
5.1
8.1
24
47
V03AE03
ATC
lanthanum carbonate; oral
5.1
8.1
24
47
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
2.7
8.1
53
199
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
3.9
8.1
31
79
C38.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of heart, mediastinum and pleura
33.4
8.1
10
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.0
8.1
96
480
SPAT1231
SPAT
Assessment of adjustments needed in living environment
1.9
8.0
105
546
L01XE04
ATC
[U] sunitinib; oral
4.8
8.0
25
52
E05.9
ICD-10 Finland
Thyrotoxicosis, unspecified
2.0
8.0
96
482
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
4.0
8.0
30
75
I31.1
ICD-10 Finland
Chronic constrictive pericarditis
10.0
8.0
15
15
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
1.9
8.0
115
619
L01XK02
ATC
niraparib; oral
22.0
8.0
11
5
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.6
8.0
189
1183
FWW96
NOMESCO Finland
Other reoperation on heart or major thoracic vessels
5.8
8.0
21
36
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
4.0
7.9
30
76
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
2.5
7.9
60
246
H3603, E103
ICD-10 Finland
NA
3.1
7.9
40
128
I51.4
ICD-10 Finland
Myocarditis, unspecified
4.4
7.9
27
62
TK820
NOMESCO Finland
Peritoneal dialysis
4.4
7.9
27
62
ZPB40
NOMESCO Finland
Polytetrafluoroethylene
3.7
7.9
32
86
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.6
7.9
55
214
3AC01
NOMESCO Finland
NA
2.7
7.9
52
197
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
7.9
2938
27129
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
3.4
7.9
36
107
A99
ICPC
Disease/condition unspecnature/site
1.4
7.9
330
2351
R03BA02
ATC
budesonide; inhalant
1.3
7.9
653
5183
GDB10
NOMESCO Finland
Wedge resection of lung
7.7
7.9
17
22
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
2.6
7.8
55
216
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
2.0
7.8
92
459
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
3.7
7.8
32
87
A01AB09
ATC
miconazole; local oral
1.4
7.8
366
2661
WX130
NOMESCO Finland
Interpleural anesthesia
8.4
7.8
16
19
A02BA02
ATC
ranitidine; systemic
1.2
7.8
943
7844
TK830
NOMESCO Finland
Ultrafiltration
10.8
7.8
14
13
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.2
7.8
75
344
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
2.4
7.8
61
254
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
2.4
7.8
64
273
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.5
7.7
236
1573
103
Kela drug reimbursment
Diabetes, insulin-treated
1.2
7.7
1394
12083
C50.9
ICD-10 Finland
Malignant neoplasm: Breast, unspecified
3.7
7.7
31
83
PH1YT
NOMESCO Finland
Endovascular insertion of stent to veins of upper extremity or to superior vena cava
45.0
7.7
9
*
L01XE35
ATC
[U] osimertinib; oral
45.0
7.7
9
*
Y60.6
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during aspiration, puncture and other catheterization
15.0
7.7
12
8
D07AC01
ATC
betamethasone; topical
1.2
7.7
1477
12875
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.3
7.7
633
5018
A10BB12
ATC
glimepiride; oral
1.4
7.7
419
3122
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.0
7.7
96
493
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
3.0
7.7
41
137
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1.8
7.6
127
717
FJA10
NOMESCO Finland
Transvenous biopsy of right ventricle
4.1
7.6
28
69
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
2.3
7.6
66
288
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.5
7.6
215
1406
L01XE02
ATC
[U] gefitinib; oral
18.4
7.6
11
6
C08DB01
ATC
diltiazem; oral
1.4
7.6
308
2182
S22.0
ICD-10 Finland
Fracture of thoracic vertebra
2.0
7.6
90
450
GDG10
NOMESCO Finland
Bilateral transplantation of lung
25.0
7.6
10
*
GX2C5
NOMESCO Finland
Short-lasting oximetry
11.8
7.6
13
11
ZXD00
NOMESCO Finland
Emergency procedure
1.7
7.6
139
811
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
7.5
1382
11992
R4180
NOMESCO Finland
Podiatric therapy
2.7
7.5
48
176
J98.4
ICD-10 Finland
Other disorders of lung
10.0
7.5
14
14
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.5
7.5
241
1624
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.4
7.5
60
253
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.0
7.5
86
427
N05AH02
ATC
clozapine; systemic
2.5
7.5
53
209
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
1.9
7.5
109
592
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
2.2
7.5
68
305
Z3229
NOMESCO Finland
Other healthcare associate professional
1.4
7.5
384
2839
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
2.9
7.4
41
140
289
Kela drug reimbursment
Combination product containing sacubitril and valsartan
2.7
7.4
46
169
8000/3-C38.4
ICD-O-3
Neoplasm, malignant of pleura, NOS
80.2
7.4
8
*
K56.7
ICD-10 Finland
Ileus, unspecified
2.0
7.4
87
436
XW5WT
NOMESCO Finland
Other blood specimen with radiologicl guidance
6.4
7.4
18
28
J85.1
ICD-10 Finland
Abscess of lung with pneumonia
6.4
7.4
18
28
A15.1
ICD-10 Finland
Tuberculosis of lung, confirmed by culture only
6.4
7.4
18
28
ZX108
NOMESCO Finland
Inhalation
3.3
7.4
34
102
C02AC05
ATC
moxonidine; oral
1.5
7.4
211
1387
AB2
HP
AVR bio, stent
2.5
7.4
53
212
R5140
NOMESCO Finland
Monitoring the use of the aid
1.4
7.4
413
3096
R52.0
ICD-10 Finland
Acute pain
1.9
7.4
104
559
R03DA04
ATC
theophylline; systemic, rectal
1.4
7.4
284
1991
WX250
NOMESCO Finland
Intercostal blockade
6.0
7.4
19
32
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
2.7
7.4
48
181
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
0.4
7.4
24
640
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
1.5
7.3
218
1444
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
2.5
7.3
52
206
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.3
7.3
593
4695
SPAT1251
SPAT
Organisation of medication
1.6
7.3
177
1116
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
8.3
7.3
15
18
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.4
7.3
318
2279
GAC34
NOMESCO Finland
Endoscopic mechanical pleurodesis
+∞
7.3
7
*
J99.0
ICD-10 Finland
Rheumatoid lung disease
+∞
7.3
7
*
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
4.5
7.2
24
54
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
5.1
7.2
21
41
WX726
NOMESCO Finland
High-flow oxygen therapy
15.7
7.2
11
7
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.3
7.2
466
3568
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
2.8
7.2
43
154
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
2.6
7.2
48
184
M05
ICD-10 Finland
Seropositive rheumatoid arthritis
3.0
7.2
39
132
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
1.9
7.2
98
521
169
Kela drug reimbursment
Crizotinib
30.0
7.1
9
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
2.3
7.1
63
279
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
1.9
7.1
98
522
3A064
NOMESCO Finland
NA
3.8
7.1
28
74
5861
FHL
Pleural biopsy or removal of local change
20.0
7.1
10
5
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
4.8
7.1
22
46
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
1.6
7.1
162
1007
B90.9
ICD-10 Finland
Sequelae of respiratory and unspecified tuberculosis
3.2
7.1
35
111
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
2.1
7.1
71
335
N05AH04
ATC
quetiapine; oral
1.3
7.0
535
4194
AN2
HP
Balloon angioplasty, including several vessels
1.6
7.0
153
937
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
8.8
7.0
14
16
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
8.8
7.0
14
16
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.6
7.0
47
181
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
1.7
7.0
129
755
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
10.0
7.0
13
13
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
4.3
7.0
24
56
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
4.7
7.0
22
47
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
3.3
7.0
32
96
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
2.8
7.0
41
145
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
2.6
7.0
49
192
I27.9
ICD-10 Finland
Pulmonary heart disease, unspecified
3.4
7.0
31
91
UJF92
NOMESCO Finland
Capsular endoscopy
2.1
7.0
72
342
SPAT1139
SPAT
Nutrition survey
1.7
7.0
132
780
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
2.9
7.0
40
138
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
7.0
354
2613
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
1.8
6.9
112
630
FPG30
NOMESCO Finland
Implantation of cardioverter-defibrillator with ventricular electrode
3.0
6.9
37
124
I26
ICD-10 Finland
Pulmonary embolism
2.8
6.9
41
146
Z29.0
ICD-10 Finland
Isolation
3.6
6.9
29
81
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
2.2
6.9
64
289
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.3
6.9
410
3100
K86.1
ICD-10 Finland
Other chronic pancreatitis
2.6
6.9
47
183
SPAT1301
SPAT
No procedures
1.2
6.9
1436
12589
M31.3
ICD-10 Finland
Wegener granulomatosis
5.1
6.9
20
39
XF614
NOMESCO Finland
Measurement of pulmonary artery pressure
5.8
6.9
18
31
I30.0
ICD-10 Finland
Acute nonspecific idiopathic pericarditis
7.5
6.9
15
20
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.1
6.9
76
371
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.3
6.9
477
3694
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
2.5
6.9
50
202
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
4.6
6.9
22
48
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
4.6
6.9
22
48
I44.2
ICD-10 Finland
Atrioventricular block, complete
1.6
6.9
150
924
LCD00
NOMESCO Finland
Hysterectomy
1.7
6.9
126
739
FKD10
NOMESCO Finland
Replacement of mitral valve using biological prosthesis
3.5
6.8
29
82
L01CB01
ATC
etoposide; systemic
3.5
6.8
29
82
R07.3
ICD-10 Finland
Other chest pain
1.4
6.8
380
2845
NB1AE
NOMESCO Finland
Shoulder ultrasound examination
2.1
6.8
76
373
C08DA01
ATC
verapamil; systemic
1.5
6.8
194
1274
SPAT1234
SPAT
Support of social functional capacity
1.5
6.8
234
1601
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
4.8
6.8
21
44
S22.4
ICD-10 Finland
Multiple fractures of ribs
1.9
6.8
97
523
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.6
6.8
167
1058
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
2.4
6.8
52
215
FKD00
NOMESCO Finland
Replacement of mitral valve using mechanical prosthesis
5.0
6.8
20
40
K70.9
ICD-10 Finland
Alcoholic liver disease, unspecified
4.1
6.8
24
58
G62.1
ICD-10 Finland
Alcoholic polyneuropathy
4.1
6.8
24
58
I20.00
ICD-10 Finland
Unstable angina
1.6
6.8
184
1195
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
6.8
110
618
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.0
6.8
86
443
NHG76
NOMESCO Finland
Arthroplasty of other tarsometatarsal joint
2.3
6.8
60
266
TPX15
NOMESCO Finland
Removal of vascular injection port
4.0
6.8
25
63
GDW96
NOMESCO Finland
Other operation on lung
40.1
6.8
8
*
FEF10
NOMESCO Finland
Subtotal pericardiectomy
40.1
6.8
8
*
NA2AD
NOMESCO Finland
Thoracic spine CT examination
3.6
6.7
28
78
I40.9
ICD-10 Finland
Acute myocarditis, unspecified
3.6
6.7
28
78
JDB10
NOMESCO Finland
Percutaneous gastrostomy
2.2
6.7
61
275
PE1AT
NOMESCO Finland
Femoral artery PTA
2.2
6.7
66
308
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
1.6
6.7
157
984
R60.9
ICD-10 Finland
Oedema, unspecified
1.5
6.7
193
1271
JBA10
NOMESCO Finland
Transabdominal biopsy or excision of lesion of diaphragm
16.7
6.7
10
6
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
2.3
6.7
60
267
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
2.6
6.7
45
174
1XC07
NOMESCO Finland
NA
4.7
6.7
21
45
RJ120
NOMESCO Finland
NA
7.2
6.7
15
21
A40.8
ICD-10 Finland
Other streptococcal sepsis
2.6
6.7
47
184
B01AC04
ATC
clopidogrel; oral
1.2
6.7
876
7340
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
4.1
6.7
24
59
3001
Kela drug reimbursment
Alectinib
22.5
6.7
9
*
J86
ICD-10 Finland
Pyothorax
22.5
6.7
9
*
1504
Kela drug reimbursment
Alectinib
22.5
6.7
9
*
1CD02
NOMESCO Finland
NA
3.1
6.7
34
111
SPAT1260
SPAT
Consultation of another employee
1.2
6.6
747
6158
I47.2
ICD-10 Finland
Ventricular tachycardia
1.8
6.6
109
616
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
4.4
6.6
22
50
71239
ICD-8 Finland
Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD
2.6
6.6
44
169
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
3.1
6.6
33
106
159
Kela drug reimbursment
Pazopanib
5.1
6.6
19
37
Z94.1
ICD-10 Finland
Heart transplant status
5.1
6.6
19
37
AS4
HP
Physiological pacemaker insertion DDD (R)
2.0
6.6
79
401
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
5.9
6.6
17
29
D72.1
ICD-10 Finland
Eosinophilia
4.2
6.6
23
55
FN1CC
NOMESCO Finland
Very extensive angiography of heart and/or coronary arteries
1.9
6.6
89
471
RS221
NOMESCO Finland
NA
2.2
6.6
59
264
M35.1
ICD-10 Finland
Other overlap syndromes
3.9
6.5
25
65
JAL00
NOMESCO Finland
Biopsy of peritoneum
3.7
6.5
26
70
K56.0
ICD-10 Finland
Paralytic ileus
2.3
6.5
57
253
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
2.6
6.5
46
180
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
2.8
6.5
38
134
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
6.5
133
805
GBB00
NOMESCO Finland
Tracheostomy
2.3
6.5
56
246
EB1WA
NOMESCO Finland
NA
3.1
6.5
32
102
J01FA15
ATC
telithromycin; oral
1.4
6.5
327
2407
ZZA00
NOMESCO Finland
Split skin graft
1.6
6.5
141
866
M01AH02
ATC
rofecoxib; oral
1.3
6.5
579
4638
H3603, E113
ICD-10 Finland
NA
2.4
6.5
50
208
N05AF03
ATC
chlorprothixene; systemic
2.0
6.5
82
423
L82
ICD-10 Finland
Seborrhoeic keratosis
0.8
6.5
404
5160
J02AC01
ATC
fluconazole; systemic
1.2
6.5
1258
10954
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
1.7
6.5
136
829
V03AA01
ATC
NA
2.0
6.5
73
361
QD6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in foot
5.3
6.4
18
34
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
1.7
6.4
127
761
R13
ICD-10 Finland
Dysphagia
1.4
6.4
273
1950
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
2.3
6.4
53
229
J92
ICD-10 Finland
Pleural plaque
69.9
6.4
7
*
L01XE16
ATC
[U] crizotinib; oral
69.9
6.4
7
*
N06AX16
ATC
venlafaxine; oral
1.3
6.4
381
2885
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
2.7
6.4
39
143
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.4
6.4
285
2053
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
14.3
6.4
10
7
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
1.7
6.4
116
679
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
6.3
196
1315
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
6.3
117
685
RD210
NOMESCO Finland
NA
2.2
6.3
61
284
R55
ICD-10 Finland
Syncope and collapse
1.3
6.3
527
4188
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
2.0
6.3
70
345
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
2.6
6.3
42
162
JFB30
NOMESCO Finland
Right hemicolectomy
2.0
6.3
76
385
9284
FHL
Wrist ossification surgery
5.9
6.3
16
27
D638, N188
ICD-10 Finland
NA
9.2
6.3
12
13
R05FB02
ATC
cough suppressants and expectorants
1.2
6.3
1716
15371
GD1AA
SPAT
NA
1.6
6.3
163
1052
KAC10
NOMESCO Finland
Total nephrectomy with capsule
2.4
6.2
48
199
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
2.6
6.2
41
156
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
2.0
6.2
72
361
J99.1
ICD-10 Finland
Respiratory disorders in other diffuse connective tissue disorders
+∞
6.2
6
*
5120A
ICD-9 Finland
Pneumothorax, Spontaneous tension pneumothorax
+∞
6.2
6
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
1.9
6.2
84
443
K72.9
ICD-10 Finland
Hepatic failure, unspecified
3.1
6.2
31
100
GWW96
NOMESCO Finland
Other reoperation in thoracic surgery
26.7
6.2
8
*
GAW97
NOMESCO Finland
Other thoracoscopic operation on chest wall, pleura and diaphragm
26.7
6.2
8
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
2.0
6.2
71
352
N17.0
ICD-10 Finland
Acute renal failure with tubular necrosis
2.7
6.2
38
140
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
4.3
6.2
21
49
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
4.3
6.2
21
49
8000/3-C34.1
ICD-O-3
Neoplasm, malignant of upper lobe, lung
4.3
6.2
21
49
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
4.3
6.2
21
49
E10
ICD-10 Finland
Type 1 diabetes mellitus
2.3
6.2
54
239
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
7.0
6.2
14
20
293
Kela drug reimbursment
Baricitinib
7.0
6.2
14
20
3006
Kela drug reimbursment
Baricitinib
7.0
6.2
14
20
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.3
6.2
406
3122
J46
ICD-10 Finland
Status asthmaticus
1.8
6.2
96
535
T90
ICPC
Diabetes non-insulin dependent
1.2
6.2
1090
9404
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
2.1
6.2
64
306
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
2.6
6.2
41
158
Z94.4
ICD-10 Finland
Liver transplant status
5.0
6.2
18
36
I49.5
ICD-10 Finland
Sick sinus syndrome
1.5
6.2
197
1333
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
6.2
31
101
I20.90
ICD-10 Finland
Angina pectoris, unspecified
1.5
6.1
204
1390
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.4
6.1
280
2032
ZXE90
NOMESCO Finland
More than 22 hours
2.4
6.1
48
203
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
2.3
6.1
53
234
R60.1
ICD-10 Finland
Generalized oedema
3.4
6.1
27
80
R63.4
ICD-10 Finland
Abnormal weight loss
1.6
6.1
147
932
62
HP
Catheterization and pressure measurement of the right side of the heart
3.2
6.1
29
91
168
Kela drug reimbursment
Axitinib
12.5
6.1
10
8
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
2.5
6.1
44
178
AP3
HP
Catheterization of the right and left side of the heart
4.0
6.1
22
55
J37.0
ICD-10 Finland
Chronic laryngitis
1.7
6.1
115
683
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
1.7
6.1
115
683
I34.2
ICD-10 Finland
Nonrheumatic mitral (valve) stenosis
3.7
6.1
24
65
Z51.88
ICD-10 Finland
Other specified medical care
1.9
6.0
85
459
WX213
NOMESCO Finland
Lower leg blockade
2.7
6.0
38
143
M01AX17
ATC
nimesulide; oral
1.2
6.0
1082
9347
I47.1
ICD-10 Finland
Supraventricular tachycardia
1.6
6.0
165
1075
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
4.9
6.0
18
37
-1
NOMESCO Finland
NA
1.2
6.0
1126
9763
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
3.3
6.0
27
81
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
2.1
6.0
60
281

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3014891) Appearance of Pleural fluid
201
57
36.39
322.10
1.9
1.3
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
204
65
32.40
316.02
1.4
1.2
mmol/l
1.8
1.3
1.59
173
28
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
168
24
71.88
310.62
1.2
1.1
u/l
17.3
15.2
0.27
126
13
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1548
5807
3.21
310.23
3.4
4.1
ug/l
16.8
19.6
0.29
1297
4824
(3023368) Bacteria identified in Blood by Culture
3144
15871
2.95
307.65
6.3
4.2
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
381
73
55.47
307.65
1.6
1.2
%
19.3
23.5
0.62
336
51
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
1280
961
16.45
307.65
1.9
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
1531
286
70.31
307.65
1.5
1.2
u/l
398.3
324.3
0.99
1478
266
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
995
1421
8.12
307.65
1.8
1.6
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
180
20
92.61
307.65
1.2
1.1
g/l
18.7
12.6
2.59
174
14
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
607
129
51.94
307.65
1.6
1.2
%
64.7
61.4
0.45
522
98
(3020630) Protein [Mass/volume] in Serum or Plasma
2093
4636
6.25
307.65
2.4
2.5
g/l
64.2
66.3
22.31
2011
4112
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
622
54
127.64
307.65
1.4
1.1
ug/l
193.0
634.3
0.39
351
25
(3023383) Lactate [Moles/volume] in Pleural fluid
550
81
74.27
307.65
1.4
1.3
mmol/l
3.7
3.5
0.19
511
72
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
1367
181
96.08
307.65
1.4
1.1
u/l
14.3
13.0
0.34
1320
153
(44786800) Granulocytes/100 leukocytes in Body fluid
278
28
103.80
307.65
1.4
1.3
%
22.6
18.7
0.30
228
20
(3042631) Mycobacterium sp identified in Specimen
565
658
9.33
307.65
2.5
2.6
—
—
—
0
0
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
249
44
58.87
307.65
1.6
1.2
%
10.0
11.1
0.11
150
16
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1485
1689
11.18
307.65
2.5
2.6
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
1624
387
56.12
307.65
1.7
1.3
e6/l
67522.1
25447.1
4.82
1063
204
(3000919) Neutrophils/100 leukocytes in Pleural fluid
469
91
55.59
307.65
1.5
1.2
%
18.2
28.5
2.52
438
79
(3012441) Differential panel - Pleural fluid
1602
347
61.49
307.65
1.7
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
1375
310
56.40
307.65
1.5
1.2
mmol/l
5.9
7.1
6.95
1297
282
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
1199
189
78.05
307.65
1.5
1.3
u/l
12.6
14.1
1.64
1170
177
(3042936) Bacteria identified in Isolate by Culture
2447
7200
4.91
307.65
2.5
2.0
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
1724
435
54.11
307.65
1.7
1.2
e6/l
2496.5
2396.3
0.05
1322
285
(3035880) pH of Pleural fluid
890
172
60.06
307.65
1.4
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
1669
327
68.98
307.65
1.9
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
2044
473
63.37
307.65
1.7
1.2
g/l
36.2
28.4
29.88
1931
392
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2222
6470
4.75
307.65
3.8
4.0
u/l
237.7
246.2
1.59
2164
6047
(3001893) Eosinophils/100 leukocytes in Pleural fluid
535
93
62.75
307.65
1.6
1.3
%
2.9
2.4
0.25
471
75
(3045788) Cell count panel - Pleural fluid
1214
356
41.97
307.65
1.8
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
3082
16697
2.65
307.41
8.5
5.4
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
3680
21768
2.65
305.48
8.9
5.6
%
0.6
0.7
7.34
3546
20037
(3019069) Monocytes/100 leukocytes in Blood
3745
22483
2.63
299.16
9.3
6.0
%
9.2
8.9
5.22
3609
20730
(3006504) Eosinophils/100 leukocytes in Blood
3733
22381
2.63
298.96
8.9
5.6
%
2.6
2.9
15.41
3602
20560
(3001604) Monocytes [#/volume] in Blood
3866
23734
2.62
292.01
8.5
5.3
e9/l
0.7
0.6
20.35
3409
20072
(3006315) Basophils [#/volume] in Blood
3881
23896
2.62
290.92
8.5
5.4
e9/l
0.0
0.0
0.83
3430
20242
(3002030) Lymphocytes/100 leukocytes in Blood
3766
22919
2.59
288.31
9.1
5.8
%
21.4
26.4
128.30
3622
20986
(3019198) Lymphocytes [#/volume] in Blood
3906
24336
2.58
282.06
8.7
5.5
e9/l
1.6
1.9
10.86
3496
20933
(3013115) Eosinophils [#/volume] in Blood
3936
24642
2.58
280.81
9.0
5.5
e9/l
0.2
0.2
2.47
3512
21137
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
156
32
49.96
270.11
1.6
1.3
%
73.5
80.9
0.93
136
24
(3042010) Triglyceride [Moles/volume] in Pleural fluid
165
46
36.80
265.41
1.4
1.2
mmol/l
1.0
2.7
0.46
135
22
(3018010) Neutrophils/100 leukocytes in Blood
3651
22593
2.46
258.77
8.7
5.6
%
62.8
58.3
86.36
3509
20816
(3014111) Lactate [Moles/volume] in Serum or Plasma
1311
4921
3.10
257.94
6.9
6.2
mmol/l
1.3
1.4
1.31
1251
4698
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1865
8469
2.70
257.16
5.2
3.0
mmol/l
0.8
0.8
3.71
1771
7821
(3032080) INR in Blood by Coagulation assay
3687
22989
2.45
255.84
15.7
10.8
inr
1.4
1.4
0.36
1070
6215
(3013650) Neutrophils [#/volume] in Blood by Automated count
4195
27794
2.51
253.27
16.2
8.3
e9/l
4.7
4.3
15.63
3801
23930
(4035726)
1196
4342
3.16
248.51
1.5
1.3
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
152
41
37.96
246.59
1.4
1.3
u/l
91.5
1176.3
0.52
128
21
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
3017
17590
2.37
238.37
4.5
3.1
ng/l
2886.9
1796.7
13.97
2753
15161
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
4020
26656
2.39
233.71
10.8
6.0
umol/l
11.7
12.4
2.16
3889
25205
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
415
714
6.15
231.69
1.6
1.9
ug/l
20.4
23.5
0.58
403
699
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1893
9230
2.50
220.00
2.3
1.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
3548
23017
2.23
206.81
7.7
4.7
g/l
31.6
34.8
156.62
3358
21167
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
763
2382
3.51
200.33
2.3
1.8
ug/l
3.7
2.7
0.25
706
2073
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
362
629
6.04
199.71
1.2
1.1
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1752
8623
2.43
196.05
2.8
1.9
s
31.2
30.2
6.60
1701
8367
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
449
983
4.84
191.39
1.6
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
487
1162
4.46
186.47
5.0
3.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
1240
5314
2.66
184.94
1.5
1.3
titre
514.0
498.5
0.12
301
1129
(3009445) Proteinase 3 Ab [Units/volume] in Serum
685
2113
3.51
182.58
1.5
1.4
u/ml
27.0
12.3
0.61
17
44
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
679
2118
3.47
177.70
3.3
2.8
u/ml
0.3
0.3
0.73
379
1205
(3009343) pH of Capillary blood
920
3451
2.95
176.42
5.4
3.2
ph
7.4
7.4
0.08
151
398
(3020779) Urea [Moles/volume] in Serum or Plasma
1208
5226
2.62
175.98
11.2
6.4
mmol/l
12.4
11.0
6.43
1144
4922
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
928
3505
2.93
175.70
5.4
3.2
kpa
5.3
5.1
11.64
880
3178
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
478
1177
4.31
175.50
2.1
1.4
g/l
1.0
1.2
10.78
456
1114
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
468
1136
4.37
175.06
2.0
1.4
g/l
0.2
0.2
0.03
449
1077
(3044416) Complement C4 [Mass/volume] in Pleural fluid
94
13
73.38
174.14
1.2
1.1
g/l
0.1
0.1
—
78
7
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
893
3326
2.96
173.28
5.3
3.1
mmol/l
2.7
1.5
14.85
727
2352
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1547
7673
2.35
166.36
3.5
2.6
%
19.6
22.2
11.62
1357
6427
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
3521
24121
2.04
161.67
10.3
5.8
mmol/l
1.2
1.2
14.80
3303
21587
(3022948) Iron [Moles/volume] in Serum or Plasma
1688
8790
2.26
161.00
3.4
2.5
umol/l
10.2
12.4
35.39
1570
8055
(3027315) Oxygen [Partial pressure] in Blood
451
1141
4.18
159.45
6.5
3.5
kpa
8.2
8.5
2.68
444
1114
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1602
8192
2.28
159.43
3.4
2.5
g/l
2.1
2.3
13.40
1494
7509
(3013290) Carbon dioxide [Partial pressure] in Blood
449
1135
4.18
158.91
6.5
3.4
kpa
5.1
4.9
7.23
442
1109
(3012501) Base excess in Blood by calculation
449
1135
4.18
158.91
6.5
3.4
mmol/l
3.2
2.4
6.83
353
746
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
826
3085
2.93
158.74
8.3
6.3
mmol/l
25.4
24.6
7.17
820
3058
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1350
6440
2.39
157.74
8.7
6.4
kpa
5.2
5.0
9.44
1289
6101
(3027801) Oxygen [Partial pressure] in Arterial blood
1347
6438
2.39
156.59
8.7
6.4
kpa
11.0
12.1
14.67
1287
6090
(3003396) Base excess in Arterial blood by calculation
1341
6416
2.38
155.40
8.7
6.4
mmol/l
1.8
0.8
12.54
1116
4878
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
447
1145
4.12
155.34
1.7
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1435
7096
2.32
153.95
9.2
5.6
mmol/l
1.1
1.0
11.27
1344
6506
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3760
26645
2.01
153.63
11.9
6.5
mmol/l
1.2
1.2
15.82
3129
22323
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
1325
6382
2.36
150.74
2.2
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
431
1101
4.13
150.25
1.7
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
1323
6406
2.35
148.46
2.2
1.7
—
—
—
0
0
(3010421) pH of Blood
477
1329
3.80
147.21
6.5
3.4
ph
7.4
7.4
0.10
443
1112
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
362
845
4.48
141.93
1.7
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
412
1091
3.97
136.49
1.6
1.8
mg/l
10.3
12.5
3.03
392
993
(3005719) IgG [Mass/volume] in Serum or Plasma
814
3270
2.71
135.16
3.0
2.6
g/l
10.7
10.6
0.17
747
2957
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
346
825
4.38
131.90
1.6
1.3
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
519
1642
3.35
131.63
1.7
1.5
titre
345.3
229.6
0.35
19
77
(3019060) Gas panel - Arterial blood
862
3619
2.60
130.74
5.8
4.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
1186
5795
2.29
128.43
9.3
6.7
%
94.3
95.7
9.23
1152
5566
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
459
1365
3.55
128.20
1.5
1.4
iu/ml
9.6
18.5
0.91
16
29
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
544
1803
3.21
127.76
1.6
1.7
u/l
36.1
38.5
1.65
464
1536
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
241
435
5.72
127.30
1.3
1.2
—
—
—
0
0
(3018418) pH of Serum or Plasma
2444
15639
1.92
127.01
6.9
3.9
ph
7.4
7.4
0.84
630
2876
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
301
663
4.72
126.71
1.7
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
301
676
4.63
123.70
1.6
1.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
674
2568
2.82
123.43
2.0
1.8
g/l
1.3
1.4
0.60
620
2286
(40767503) Oxygen content in Capillary blood by calculation
403
1134
3.73
122.18
3.3
2.3
%
15.3
16.1
3.22
217
602
(3036481) Cortisol [Moles/volume] in Serum or Plasma
882
3926
2.45
117.41
2.7
2.2
nmol/l
398.5
375.4
1.68
820
3575
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
782
3300
2.56
116.64
1.7
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
259
540
4.96
116.38
1.8
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
4029
30697
1.86
116.23
8.3
4.7
mmol/l
6.9
6.9
0.59
3902
28814
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
286
649
4.57
115.97
1.5
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
991
4678
2.33
115.38
10.7
7.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
266
573
4.80
114.96
2.2
2.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
874
3916
2.43
114.50
1.9
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
306
743
4.28
113.75
1.5
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
1012
4847
2.30
113.75
2.5
2.1
g/l
0.2
0.2
21.38
929
4465
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
403
1201
3.52
111.93
1.7
1.6
iu/ml
3.9
12.2
0.62
102
281
(3033658) Prothrombin time (PT) actual/Normal
2054
12829
1.89
111.66
7.6
3.9
%
80.5
84.2
8.22
2004
12506
(3028626) Oxygen [Partial pressure] in Capillary blood
411
1246
3.46
111.14
3.7
2.5
kpa
7.8
7.9
1.21
383
1131
(3022313) Gas panel - Capillary blood
637
2493
2.73
110.33
5.7
3.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
246
519
4.89
108.96
3.5
3.6
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
900
4239
2.31
104.62
5.1
3.8
%
1.1
0.9
0.85
366
1267
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1704
10194
1.92
104.46
2.1
1.7
mg/l
2.0
1.5
5.50
1425
7866
(40760892) CBC W Ordered Manual Differential panel - Blood
1624
9586
1.93
103.51
6.9
4.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1293
7052
2.05
103.40
3.0
2.4
%
1.9
1.7
4.69
1151
6125
(46235355) HIV 1 and 2 tests - Meaningful Use set
993
4911
2.21
102.45
1.8
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
688
2911
2.53
101.38
9.7
8.3
mmol/l
24.9
24.0
8.41
640
2668
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
2385
15986
1.79
100.62
3.4
2.5
u/l
57.3
59.1
0.53
2230
14706
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2945
21020
1.75
99.53
5.7
4.0
ng/l
65.7
89.7
0.44
2451
16036
(3002179) Metamyelocytes/100 leukocytes in Blood
823
3812
2.33
99.15
4.8
3.7
%
0.7
0.7
0.18
269
877
(3021901) Oxygen saturation in Capillary blood
356
1059
3.50
98.98
3.5
2.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
852
4025
2.29
97.93
5.1
3.9
%
0.2
0.1
0.25
346
1172
(3015235) Bicarbonate [Moles/volume] in Capillary blood
430
1450
3.11
97.47
3.9
2.7
mmol/l
25.5
24.4
4.32
382
1236
(3002032) Base excess in Venous blood by calculation
1043
5447
2.10
92.84
5.9
3.6
mmol/l
2.3
1.7
5.14
876
4343
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1043
5458
2.09
92.29
5.9
3.6
kpa
6.0
5.8
7.78
1009
5272
(3002582) Erythrocytes [#/volume] in Urine
2432
16720
1.74
91.65
4.3
3.4
e6/l
142.4
120.4
0.18
1970
13097
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
445
1585
2.94
91.50
10.1
3.6
u/ml
213.0
60.2
4.20
438
1524
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
2141
14209
1.77
91.30
2.8
2.3
mg/l
3.4
3.0
9.41
1865
11933
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4682
38599
1.82
91.03
14.7
7.4
u/l
90.1
80.4
20.35
4548
36057
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
199
409
4.99
90.84
1.7
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
1756
11016
1.82
90.44
3.7
2.8
mosm/kgh2o
517.8
561.1
16.71
1564
9360
(3028271) Lactate [Moles/volume] in Capillary blood
293
815
3.72
90.03
2.4
1.8
mmol/l
1.7
1.7
0.64
287
793
(3000494) Fungus identified in Specimen by Culture
1033
5444
2.07
89.46
1.8
1.4
—
—
—
0
0
(3012544) pH of Venous blood
1061
5661
2.05
88.79
6.0
3.7
ph
7.4
7.4
—
8
26
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1014
5327
2.08
88.49
10.4
7.2
g/l
116.1
120.1
8.50
988
5128
(40758558) Short blood count panel - Blood
1902
12306
1.78
87.83
12.6
6.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2185
14819
1.72
84.81
4.7
3.1
u/l
41.0
36.8
0.65
2064
13928
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
158
283
5.70
84.04
1.5
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
773
3739
2.22
83.13
5.2
3.9
%
0.3
0.2
0.16
292
965
(3021589) Normoblasts [#/volume] in Blood
2865
21046
1.66
81.28
18.5
9.8
e9/l
0.0
0.0
0.04
2347
17087
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
169
332
5.20
81.24
1.5
1.3
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
147
255
5.88
80.86
3.4
3.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
155
283
5.59
80.78
1.5
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2338
16364
1.68
79.42
3.6
2.6
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2482
17651
1.67
79.27
5.8
3.3
mmol/l
2.3
2.3
9.26
2220
15020
(3030467) Casts [#/volume] in Urine by Automated count
2207
15240
1.69
78.75
4.1
3.3
e6/l
0.7
0.5
3.51
1753
11686
(3023520) Reticulocytes [#/volume] in Blood
985
5327
2.01
78.59
3.2
2.4
e9/l
69.2
67.2
0.90
745
4076
(3014576) Chloride [Moles/volume] in Serum or Plasma
1232
7204
1.88
77.88
10.2
6.4
mmol/l
103.3
104.6
14.12
1200
7046
(3004588) Protein electrophoresis panel - Serum or Plasma
814
4123
2.12
77.56
2.2
2.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
310
986
3.25
77.27
1.3
1.2
titre
508.6
89.2
—
7
13
(3017143) Hepatitis C virus Ab [Presence] in Serum
783
3913
2.14
77.24
1.8
1.5
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
2121
14555
1.69
77.10
4.0
3.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
110
148
7.55
77.05
2.0
1.9
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
229
598
3.94
76.95
1.8
1.6
g/l
1.0
0.9
0.21
172
452
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
509
2130
2.51
76.03
6.6
3.5
mmol/l
25.6
24.6
9.13
482
1916
(3023487) Leukocytes [#/volume] in Peritoneal fluid
116
170
6.93
75.26
1.8
2.3
e6/l
1272.6
5877.9
0.50
80
119
(3034860) Kappa light chains.free [Mass/volume] in Serum
478
1966
2.55
73.99
2.8
3.1
mg/l
69.9
93.7
0.38
372
1614
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
477
1962
2.55
73.83
2.8
3.1
mg/l
73.0
50.5
0.40
373
1612
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
628
2927
2.27
73.49
1.7
1.6
g/l
1.7
1.5
2.07
523
2487
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
1007
5614
1.94
73.15
5.4
3.5
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
590
2687
2.32
72.90
6.1
3.9
mmol/l
24.2
23.9
1.20
545
2383
(3018095) Leukocytes [#/volume] in Urine
2579
18819
1.63
72.47
5.2
3.9
e6/l
115.8
110.8
0.10
2032
13907
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
466
1915
2.55
72.23
2.9
3.1
ratio
1.7
2.7
1.03
36
138
(3000850) Epithelial cells [#/volume] in Urine
1774
11785
1.70
71.77
3.5
2.7
e6/l
5.3
4.3
1.18
1612
10300
(40760888) Immunoglobulin light chains.free panel - Serum
386
1458
2.75
70.82
2.7
3.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
706
3505
2.14
70.51
2.1
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
813
4259
2.04
70.35
1.8
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1658
10866
1.71
70.26
5.4
4.0
ng/l
448.6
523.3
0.24
1446
9278
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
948
5255
1.95
69.78
4.5
2.9
ng/l
366.4
245.6
8.34
887
4814
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
106
153
7.03
69.74
1.7
2.1
e6/l
15191.1
19544.5
0.12
62
87
(3022217) INR in Platelet poor plasma by Coagulation assay
1366
8506
1.77
69.30
33.7
29.8
inr
1.6
1.5
1.56
186
1180
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
242
707
3.52
68.98
7.7
6.4
mg/l
12.1
12.1
0.01
226
643
(4281824)
169
391
4.41
66.74
1.3
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
543
2485
2.30
66.12
1.4
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
159
357
4.54
65.22
1.9
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
1019
5943
1.85
63.68
2.1
1.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1820
12485
1.64
63.62
3.3
2.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
348
1320
2.73
63.24
2.8
2.4
g/l
3.8
3.6
1.37
335
1252
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
265
865
3.15
63.18
7.4
4.5
iu/ml
424.2
3213.9
0.76
50
128
(3028192) IgG subclass 2 [Mass/volume] in Serum
155
356
4.44
61.79
1.5
1.3
g/l
2.9
3.0
0.20
104
251
(4062490)
155
356
4.44
61.79
1.6
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
306
1103
2.86
61.23
3.4
2.6
umol/l
32.9
34.6
0.53
266
902
(3027135) IgG subclass 1 [Mass/volume] in Serum
154
356
4.41
60.89
1.5
1.3
g/l
7.3
6.7
0.88
103
250
(3024139) IgG subclass 3 [Mass/volume] in Serum
154
356
4.41
60.89
1.5
1.3
g/l
0.5
0.4
0.42
103
250
(3015171) Extractable nuclear Ab [Units/volume] in Serum
365
1448
2.61
60.65
1.3
1.2
u/ml
0.7
0.6
0.21
23
136
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
688
3575
2.04
60.39
11.4
7.9
%
1.4
1.3
1.74
681
3550
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
686
3567
2.04
60.09
11.6
7.9
%
0.6
0.7
1.71
678
3539
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
55
40
13.86
59.57
1.1
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2595
19591
1.55
59.32
4.0
2.8
ug/l
232.4
157.4
20.86
2401
17705
(3044007) Cell count panel - Peritoneal fluid
92
136
6.85
59.22
1.8
1.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
326
1238
2.72
59.07
2.8
2.1
g/l
123.6
127.9
2.09
240
903
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
965
5655
1.83
59.01
3.6
2.7
umol/l
9.4
9.4
0.01
850
4932
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1114
6841
1.76
58.13
1.3
1.3
iu/ml
56.7
38.9
1.68
380
2058
(3002331) Protein [Mass/volume] in Peritoneal fluid
80
107
7.56
56.34
1.4
1.3
g/l
32.1
25.6
2.32
62
78
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
161
409
4.01
56.20
1.2
1.1
u/ml
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
805
4527
1.89
55.87
5.2
3.0
kpa
4.8
4.5
2.73
770
4356
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
397
1709
2.41
55.39
1.3
1.3
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
84
123
6.91
54.56
1.2
1.7
g/l
16.6
13.4
1.97
71
95
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
788
4436
1.89
54.43
6.5
3.7
mmol/l
1.2
1.2
6.39
734
3827
(3008152) Bicarbonate [Moles/volume] in Arterial blood
673
3594
1.98
54.43
9.6
6.3
mmol/l
25.3
24.2
9.94
637
3351
(40761536) Microorganisms panel - Urine sediment
735
4045
1.92
54.40
5.3
4.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
3994
33434
1.53
54.36
5.8
4.8
e6/l
1018.8
1745.4
0.64
77
560
(3013707) Erythrocyte sedimentation rate by Westergren method
4207
35663
1.54
53.58
6.5
4.0
mm/h
22.6
13.6
120.71
3987
32461
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
324
1289
2.60
53.45
2.3
2.2
%
83.6
88.2
2.58
312
1220
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
231
769
3.08
53.23
1.4
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
211
673
3.21
52.27
3.2
2.3
u/ml
1170.7
2962.9
0.75
16
44
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2949
23303
1.50
52.05
5.8
4.2
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
189
570
3.39
51.26
6.1
3.6
u/ml
104.6
29.8
2.38
184
550
(3004809) Band form neutrophils/100 leukocytes in Blood
258
935
2.83
51.06
3.6
3.3
%
1.6
1.6
0.03
215
688
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
309
1230
2.59
50.90
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
309
1230
2.59
50.90
1.5
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
309
1234
2.58
50.56
2.8
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
166
476
3.55
48.68
1.6
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
160
448
3.64
48.63
1.6
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
254
941
2.77
48.22
1.5
1.3
mmol/l
58.2
62.8
1.04
189
762
(40768804) Tissue Pathology biopsy report
2501
19353
1.48
47.54
2.6
2.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
314
1302
2.49
47.46
1.4
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1474
10209
1.58
47.01
4.3
3.1
mmol/l
2.5
2.5
20.73
1310
8838
(44806118)
169
503
3.42
46.81
1.7
1.3
—
—
—
0
0
(44790047)
169
503
3.42
46.81
1.7
1.3
—
—
—
0
0
(44790049)
169
503
3.42
46.81
1.7
1.3
—
—
—
0
0
(44790048)
169
503
3.42
46.81
1.7
1.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
293
1196
2.52
45.78
2.5
2.5
%
221.5
203.0
2.66
286
1139
(3037467) Urinalysis macro (dipstick) panel - Urine
4014
34263
1.47
44.74
5.9
4.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
770
4581
1.78
43.86
2.8
2.4
u/l
32.0
37.9
2.44
666
3899
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
146
413
3.60
43.72
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
146
413
3.60
43.72
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
146
413
3.60
43.72
1.5
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
299
1259
2.44
43.69
3.7
2.9
mg/l
2.1
1.7
8.28
276
1121
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
473
2403
2.05
43.69
2.4
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
559
3013
1.94
43.62
12.6
8.8
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
409
1968
2.15
43.62
2.6
2.2
ug/l
403.0
649.3
1.21
389
1870
(3007566) Smooth muscle Ab [Titer] in Serum
269
1093
2.53
42.43
1.2
1.2
titre
110.4
84.1
0.64
23
82
(4010399)
590
3286
1.88
41.60
1.5
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2100
16050
1.46
40.81
3.6
3.3
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
145
430
3.43
40.42
1.2
1.1
iu/ml
2.7
2.0
—
9
16
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
408
2031
2.08
39.75
2.7
3.4
u/ml
5187.3
2340.1
0.42
336
1741
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
434
2215
2.03
39.51
2.2
1.8
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
362
1728
2.16
39.34
2.8
2.2
g/l
0.1
0.0
0.48
331
1556
(3037692) Legionella sp identified in Specimen by Organism specific culture
78
150
5.25
38.48
1.6
1.2
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
261
1095
2.44
38.43
1.2
1.2
titre
972.5
964.8
—
8
29
(3036489) Thrombin time
353
1685
2.16
38.36
2.3
2.0
s
22.0
21.9
0.16
331
1517
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1270
8856
1.54
38.20
3.7
3.1
e6/l
2.3
1.8
1.60
701
5080
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
857
5455
1.66
37.80
2.9
2.4
ug/l
7.6
7.0
0.27
746
4693
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
337
1602
2.17
37.00
2.7
2.2
g/l
0.0
0.0
0.82
307
1435
(3018405) Lactate [Moles/volume] in Arterial blood
404
2059
2.03
36.88
5.9
3.6
mmol/l
1.3
1.5
1.85
395
2026
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
204
778
2.68
36.62
1.6
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
1594
11744
1.48
36.58
2.0
1.8
nmol/l
1259.9
1148.4
4.22
1224
8711
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
672
4040
1.74
36.57
5.5
3.8
ng/l
120.3
98.6
5.16
572
3419
(3000492) Spirometry study
634
3758
1.76
36.24
1.7
1.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
119
334
3.61
36.11
1.2
1.1
titre
285.9
112.5
0.95
22
60
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
331
1579
2.16
36.01
2.8
2.2
g/l
0.0
0.0
0.00
307
1430
(3020891) Body temperature
426
2231
1.98
36.00
7.2
4.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
446
2380
1.94
35.67
2.6
2.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
128
380
3.42
35.65
2.2
2.1
e9/l
0.9
1.1
0.73
77
238
(3017569) Oxygen content in Arterial blood
98
242
4.10
35.64
2.4
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
446
2382
1.94
35.58
2.6
2.2
g/l
7.7
7.4
2.80
349
1713
(3026493) Urate [Moles/volume] in Serum or Plasma
1826
13878
1.44
35.41
3.8
2.8
umol/l
4197.5
6084.1
1.09
1572
11778
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
419
2195
1.97
35.36
2.7
2.2
g/l
3.4
3.0
9.75
345
1680
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
444
2375
1.94
35.25
2.6
2.2
g/l
4.0
3.8
1.35
344
1646
(3035637) Corticotropin [Mass/volume] in Plasma
160
547
2.98
35.25
1.5
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
290
1332
2.23
34.66
3.1
3.1
nmol/l
0.9
0.8
0.83
226
1005
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
36
32
11.31
34.44
2.5
2.0
%
65.3
64.2
0.04
20
21
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
386
1986
2.00
34.28
2.8
2.3
g/l
0.5
1.2
5.85
338
1671
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
239
1015
2.41
34.27
1.3
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
304
1442
2.16
33.54
1.5
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
415
2210
1.94
33.36
2.6
2.2
g/l
10.7
10.3
0.67
370
1828
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
959
6457
1.57
33.24
1.3
1.2
u/ml
32.4
14.0
2.49
322
2304
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
196
771
2.59
33.08
1.2
1.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1089
7552
1.53
33.05
1.7
1.5
g/l
3.1
2.6
5.84
760
4352
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
180
679
2.70
33.03
1.6
1.4
u/ml
115.2
122.8
0.35
42
145
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
242
1054
2.35
32.78
1.3
1.2
u/ml
14.2
46.0
2.28
18
55
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
204
822
2.53
32.76
1.3
1.2
u/ml
3.0
3.6
0.13
25
54
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
229
976
2.40
32.58
1.3
1.2
u/ml
4.1
2.7
0.58
40
90
(21494815) CD4 cells/100 lymphocytes in Specimen
111
319
3.52
32.53
2.2
2.1
%
47.0
41.8
0.39
11
37
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
231
992
2.38
32.31
1.3
1.2
u/ml
5.1
6.9
0.31
56
161
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2095
16552
1.40
31.87
2.6
2.1
u/l
192.2
218.2
1.30
1975
15408
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
50
75
6.71
31.80
10.9
13.2
mmol/l
4.6
5.4
1.92
50
75
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
353
1811
2.01
31.58
2.7
2.1
g/l
34.8
37.5
11.17
318
1515
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
254
1154
2.25
31.17
1.3
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
144
506
2.89
30.24
1.1
1.2
u/l
55.3
61.8
0.66
106
334
(3023420) DNA double strand Ab [Units/volume] in Serum
120
380
3.20
30.18
1.7
1.3
iu/ml
28.0
25.1
—
6
17
(3024891) Influenza virus A+B Ag [Presence] in Specimen
243
1100
2.26
30.09
1.3
1.1
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
57
105
5.47
29.53
4.5
4.8
—
—
—
0
0
(3013512) EKG study
2008
15957
1.38
28.78
5.4
4.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
165
649
2.58
27.90
1.3
1.2
u/ml
315.8
286.3
0.59
114
395
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
95
273
3.52
27.90
2.4
2.1
e6/l
489.6
614.3
1.16
44
110
(3052851) Hemolysis interference index of Serum or Plasma
314
1626
1.98
27.34
4.5
3.5
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
97
291
3.37
26.67
1.2
1.2
u/l
112.7
90.3
0.98
86
245
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
60
127
4.76
26.58
1.1
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
106
337
3.18
26.53
1.3
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
154
602
2.60
26.39
4.3
3.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
105
336
3.16
26.01
1.2
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
138
515
2.72
25.93
1.3
1.2
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
163
663
2.50
25.72
1.6
1.5
pmol/l
468.3
206.8
2.64
154
645
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1266
9455
1.42
25.64
3.4
2.9
e6/l
1.2
1.1
0.35
700
5626
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
170
709
2.44
25.43
1.2
1.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
569
3595
1.64
25.34
5.5
3.2
g/l
117.6
127.6
21.48
560
3500
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
93
282
3.33
25.16
1.2
1.2
u/l
48.9
24.4
1.49
80
232
(3017354) Segmented neutrophils/100 leukocytes in Blood
147
576
2.59
25.08
3.2
3.1
%
60.4
59.0
0.25
98
344
(3037121) Protein [Mass/volume] in Urine
337
1844
1.87
24.88
3.1
3.0
g/l
0.4
0.3
0.64
194
783
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
28
28
10.04
24.70
2.4
1.8
%
14.4
20.4
0.27
13
16
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
84
243
3.49
24.46
1.5
1.7
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
89
268
3.35
24.35
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
89
268
3.35
24.35
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
89
268
3.35
24.35
1.1
1.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
478
2916
1.69
24.35
5.6
3.3
mmol/l
25.7
25.0
3.76
470
2823
(3026250) Tacrolimus [Mass/volume] in Blood
63
151
4.20
23.93
34.0
31.7
ug/l
7.1
7.3
0.29
58
137
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
72
191
3.80
23.83
1.6
1.9
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
89
272
3.30
23.80
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
89
272
3.30
23.80
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
89
272
3.30
23.80
1.1
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
83
243
3.45
23.74
1.5
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
83
243
3.45
23.74
1.5
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
83
243
3.45
23.74
1.5
1.7
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
91
283
3.25
23.66
2.0
2.0
%
15.1
16.0
0.15
28
116
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
161
678
2.41
23.60
1.1
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
71
188
3.81
23.56
1.6
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
71
188
3.81
23.56
1.6
1.9
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
215
1026
2.13
23.40
1.6
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
98
322
3.08
23.25
2.2
2.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
95
310
3.10
22.81
1.1
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
45
85
5.32
22.73
1.7
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
155
653
2.41
22.71
2.8
2.4
u/ml
66.6
890.5
1.14
148
640
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
446
2727
1.68
22.50
4.4
2.5
%
0.7
0.7
0.07
433
2605
(3016650) Hepatitis A virus Ab [Presence] in Serum
150
626
2.43
22.44
1.1
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
89
285
3.15
22.07
1.9
2.0
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
231
1161
2.03
21.91
2.6
3.3
u/ml
974.1
714.3
0.27
209
1064
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4363
47207
0.76
21.86
5.1
5.3
mmol/l
2.4
2.6
23.49
3831
42653
(21494814) CD8 cells/100 lymphocytes in Specimen
62
160
3.90
21.36
1.9
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
314
1766
1.82
21.24
6.8
3.8
mmol/l
4.0
3.9
1.10
288
1656
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
99
346
2.89
21.11
1.3
1.1
u/ml
62.6
46.7
—
10
26
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3262
28626
1.29
21.09
4.7
3.1
u/l
79.1
54.6
14.01
3017
25992
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
81
252
3.24
21.09
2.4
2.2
e6/l
458.5
533.2
0.50
71
216
(3038026) Centromere Ab [Units/volume] in Serum
100
352
2.87
21.05
1.3
1.1
u/ml
24.1
61.7
—
6
17
(3041096) Erythrocytes [Presence] in Urine by Automated
1546
12272
1.34
20.95
4.9
3.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
196
946
2.11
20.74
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
232
1197
1.97
20.45
4.9
2.9
—
—
—
0
0
(3004451) EKG impression Narrative
87
292
3.01
19.95
1.3
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
135
571
2.39
19.66
1.1
1.1
g/l
1.7
1.5
2.59
122
509
(40768446) Kidney Pathology biopsy report
58
152
3.84
19.58
1.5
1.6
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
63
175
3.63
19.57
35.0
23.5
ug/l
138.7
107.4
1.62
50
148
(3047181) Lactate [Moles/volume] in Blood
299
1704
1.79
19.37
8.1
5.7
mmol/l
1.3
1.3
0.04
267
1516
(4015189)
51
123
4.17
19.27
1.7
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
142
620
2.32
19.25
1.4
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
124
511
2.46
19.13
1.4
1.3
mosm/kgh2o
273.7
278.5
1.26
98
383
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
29
42
6.93
19.07
2.8
1.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1630
13193
1.32
18.97
5.5
4.2
estimate
0.0
0.0
0.02
735
4110
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
75
238
3.18
18.94
2.6
2.2
e9/l
0.2
0.2
1.87
70
214
(3024932) HLA-DR beta [Type]
48
113
4.27
18.72
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4208
45467
0.78
18.54
4.7
4.7
mmol/l
1.4
1.4
9.55
3707
40986
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5066
47436
1.34
18.52
37.5
16.3
mg/l
33.2
27.3
27.93
4785
38559
(3005322) IgE [Units/volume] in Serum or Plasma
361
2206
1.67
18.23
1.5
1.3
u/ml
223.6
237.3
0.15
331
2005
(3051651) Icteric interference index of Serum or Plasma
88
313
2.84
18.22
5.1
3.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
383
2377
1.65
18.22
1.4
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
84
292
2.90
18.14
2.5
2.3
ph
7.4
7.4
0.01
40
85
(3021601) Nitrite [Presence] in Urine by Test strip
2735
23770
1.27
17.96
6.4
5.1
estimate
0.0
0.0
0.50
801
4368
(3024471) HLA-A [Type]
48
117
4.13
17.91
1.0
1.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
124
527
2.38
17.90
3.8
3.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
145
660
2.23
17.84
1.4
1.4
—
—
—
0
0
(3025315) Body weight
27
39
6.95
17.79
4.5
5.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
142
643
2.24
17.70
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
142
644
2.23
17.63
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
142
647
2.22
17.44
1.4
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
47
116
4.07
17.26
2.8
2.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
168
824
2.07
17.10
5.0
3.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
2758
24083
1.26
17.10
5.0
3.9
estimate
0.0
0.0
0.03
768
4230
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
141
646
2.21
17.09
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
899
6742
1.39
17.09
1.3
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
382
2413
1.62
16.94
7.4
4.8
%
1.7
1.6
1.09
361
2262
(3019225) pH of Specimen
759
5542
1.42
16.84
6.7
4.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2724
23782
1.26
16.81
4.9
3.8
estimate
0.0
0.0
0.50
790
4320
(3024522) Salmonella sp identified in Specimen by Organism specific culture
141
652
2.19
16.72
1.4
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
42
99
4.26
16.39
1.1
1.1
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
53
148
3.60
16.39
1.8
1.9
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4277
45917
0.79
16.36
4.7
4.7
mmol/l
4.2
4.4
24.45
3797
41691
(3016038) Potassium [Moles/volume] in Urine
90
346
2.62
16.10
1.2
1.2
mmol/l
35.2
35.3
0.01
77
294
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
80
292
2.76
15.84
1.6
1.6
u/l
6.0
7.2
0.23
37
137
(3040151) Glucose [Moles/volume] in Capillary blood
137
651
2.13
15.20
9.1
19.0
mmol/l
7.1
7.5
0.89
122
518
(3044242) Glucose [Moles/volume] in Arterial blood
78
290
2.71
14.93
2.2
1.9
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
74
268
2.78
14.89
1.5
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
74
268
2.78
14.89
1.5
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
41
103
4.00
14.74
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
136
655
2.10
14.59
1.1
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
68
239
2.87
14.48
1.1
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
145
720
2.04
14.34
1.3
1.2
u/ml
44.8
42.0
0.07
21
73
(21494890) Protein electrophoresis panel - 24 hour Urine
132
633
2.11
14.33
1.9
1.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
68
241
2.84
14.26
1.2
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
76
288
2.66
14.05
1.3
1.4
u/l
23.7
28.3
0.66
67
232
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
355
2305
1.57
14.03
3.9
3.2
pmol/l
4.2
4.4
3.68
296
2007
(3007930) Methemoglobin/Hemoglobin.total in Blood
363
2371
1.56
13.98
7.7
4.9
%
0.8
0.9
2.94
344
2226
(40768441) Liver Pathology biopsy report
79
306
2.60
13.98
1.6
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
62
214
2.92
13.66
1.1
1.1
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
29
59
4.93
13.55
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
64
228
2.83
13.32
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
64
228
2.83
13.32
1.1
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
118
559
2.13
13.25
1.1
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
130
640
2.05
13.20
1.2
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
51
162
3.17
12.97
2.5
1.8
u/ml
570.0
24575.4
—
7
21
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
33
78
4.25
12.88
2.1
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
193
1093
1.79
12.87
1.5
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4180
44627
0.81
12.84
7.0
6.5
mmol/mol
41.7
40.9
4.77
3736
40594
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
72
280
2.59
12.68
3.2
3.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
169
932
1.84
12.31
1.6
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1021
12601
0.77
12.24
1.7
1.6
mmol/l
1.4
1.3
1.08
830
10452
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
85
366
2.34
12.06
1.4
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
236
1441
1.66
12.03
1.6
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
86
373
2.32
12.00
1.4
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
856
6705
1.32
11.98
1.3
1.4
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
34
87
3.92
11.97
5.8
3.9
u/l
42.0
41.0
0.04
14
32
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
58
208
2.81
11.97
2.7
2.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4129
43983
0.82
11.52
4.2
4.2
mmol/l
1.3
1.3
0.82
3625
39239
(3014271) Vancomycin [Susceptibility]
82
356
2.32
11.44
2.9
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1411
11839
1.25
11.34
1.8
1.7
pmol/l
22775336.7
29495771.3
0.16
1146
9571
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
124
637
1.97
11.24
1.7
1.5
%
66.3
62.4
0.61
90
410
(3016750) Collection duration of Urine
77
330
2.35
11.07
2.0
2.0
min
501.7
490.0
0.33
43
233
(3021960) Folate [Moles/volume] in Serum or Plasma
1587
13516
1.23
11.07
1.8
1.6
nmol/l
19.8
20.0
0.13
1406
11454
(3012565) Volume of 24 hour Urine
60
229
2.64
11.02
2.5
2.3
ml
1910.8
1895.7
0.04
50
191
(3001964) Herpes simplex virus Ag [Presence] in Specimen
39
117
3.35
10.92
2.2
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2608
23362
1.20
10.75
2.9
2.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2206
19461
1.21
10.72
2.6
2.2
nmol/l
76.9
78.7
1.73
1971
16979
(21494755) Public health laboratory ask at order entry panel
109
2066
0.52
10.64
1.4
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
96
459
2.11
10.62
1.3
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
72
306
2.37
10.57
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
437
3150
1.42
10.34
4.0
3.3
e9/l
4.5
4.2
0.93
322
2266
(3051611) Lipemic interference index of Serum or Plasma
114
588
1.96
10.26
4.8
3.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
76
336
2.28
10.21
1.0
1.0
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
21
42
5.01
10.03
1.2
1.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
53
201
2.65
9.90
3.7
4.0
%
58.7
53.0
1.18
53
191
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
55
213
2.60
9.85
1.1
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
58
231
2.52
9.82
5.8
4.2
mg/l
56.8
69.4
0.97
42
159
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2065
18229
1.20
9.73
5.4
4.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
39
127
3.08
9.60
2.7
2.0
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
563
4298
1.34
9.35
2.0
1.7
%
1.8
1.6
6.65
468
3621
(42529582) MDA5 Ab [Presence] in Serum by Line blot
35
109
3.22
9.28
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
35
109
3.22
9.28
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
35
109
3.22
9.28
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
35
109
3.22
9.28
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
66
289
2.30
9.11
1.5
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
66
289
2.30
9.11
1.5
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
65
283
2.31
9.09
2.8
1.8
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
58
240
2.43
9.09
2.2
2.7
%
45.4
35.3
1.91
17
86
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
25
63
3.98
9.03
1.3
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4412
46366
0.84
8.84
5.2
5.1
mmol/l
6.2
6.1
2.72
3888
41342
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
42
150
2.81
8.82
2.0
2.0
u/l
16.9
50.3
1.28
36
140
(40757373) Influenza virus identified in Isolate
33
104
3.18
8.61
1.9
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
105
561
1.89
8.58
1.2
1.2
u/ml
2.9
4.9
1.86
52
247
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
106
577
1.85
8.19
1.2
1.2
u/ml
4.7
3.5
0.23
38
180
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
151
2428
0.61
8.15
1.7
1.8
—
—
—
0
0
(3003338) MCHC [Mass/volume]
3569
38061
0.86
8.14
46.1
21.8
g/l
328.1
332.0
107.33
3520
37643
(3009214) Lutropin [Units/volume] in Serum or Plasma
139
823
1.70
8.09
1.4
1.4
u/l
12.9
10.0
1.28
112
655
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
109
602
1.82
8.05
3.4
3.4
nmol/l
5.4
17.0
0.69
109
592
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
24
66
3.65
7.72
1.2
1.3
ug/l
88.8
113.6
0.37
16
40
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
66
311
2.13
7.69
1.0
1.0
mg/l
335.7
281.2
2.91
59
273
(21494434) Karyotype in Bone marrow
95
513
1.86
7.56
1.2
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
79
401
1.98
7.56
1.4
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
70
340
2.07
7.55
1.4
1.5
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
14
25
5.61
7.53
3.9
3.6
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
15
29
5.18
7.44
1.1
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1776
19890
0.85
7.42
4.2
4.7
%
21.1
22.2
2.93
926
10519
(3047007) Chlamydophila sp Ab [Presence] in Serum
88
471
1.88
7.22
1.2
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
91
493
1.86
7.19
2.2
2.2
ml
606.2
639.9
0.36
52
304
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
129
777
1.67
7.10
1.2
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
148
926
1.61
7.02
1.3
1.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
14
27
5.19
6.96
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
14
27
5.19
6.96
1.0
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
214
1465
1.48
6.77
1.4
1.5
ug/g
240.5
266.2
1.03
139
884
(3003694) ABO and Rh group [Type] in Blood
1383
12101
1.18
6.76
1.4
1.3
—
—
—
0
0
(3019174) dRVVT (LA screen)
14
28
5.01
6.70
1.4
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
38
150
2.54
6.66
2.8
1.7
ug/l
119.2
59.1
0.93
38
143
(3030981) Hyaline casts [#/volume] in Urine by Automated count
419
3222
1.32
6.66
4.1
2.9
e6/l
0.3
0.3
0.01
412
3155
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
89
493
1.82
6.59
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
89
1546
0.57
6.58
1.4
1.5
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
90
501
1.81
6.56
1.7
1.5
%
21.1
26.9
1.22
65
320
(3039000) Anion gap in Blood
184
1230
1.51
6.55
10.6
6.6
mmol/l
10.6
11.4
2.93
168
1098
(3018572) Chloride [Moles/volume] in Blood
184
1230
1.51
6.55
10.6
6.6
mmol/l
104.1
105.3
2.46
168
1098
(3047189) Immunofixation for 24 hour Urine
61
299
2.05
6.48
1.8
1.6
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
52
240
2.18
6.45
1.5
1.3
u/ml
0.8
1.7
0.55
28
119
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
39
159
2.46
6.41
1.6
2.1
umol/l
121.7
103.5
0.25
21
95
(3000475) Leukocytes [#/volume] in Synovial fluid
189
1278
1.49
6.38
1.8
1.5
e6/l
18585.2
15799.1
0.28
147
911
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
58
282
2.07
6.31
2.6
2.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
86
480
1.80
6.24
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
357
2710
1.34
6.22
2.9
2.9
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
146
940
1.57
6.19
1.4
1.3
u/l
61.3
41.2
1.12
127
816
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
17
43
3.96
6.16
2.7
2.7
mg/l
2.0
1.2
0.41
12
33
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
512
4097
1.27
6.03
4.0
2.7
ml/min/173m2
51.4
61.4
7.37
267
1723
(3050794) Legionella sp Ab [Presence] in Serum
15
35
4.29
6.02
1.0
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
60
1131
0.53
5.92
2.6
1.6
mg/l
8.5
3.3
0.96
50
794
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
140
903
1.56
5.91
1.7
1.7
iu/l
3.2
4.5
1.07
43
275
(3043410) Blood group antigens tested for on Red Blood Cells
37
154
2.41
5.85
1.5
1.9
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
21
64
3.29
5.85
3.1
2.6
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
36
149
2.42
5.77
1.3
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
52
252
2.07
5.74
1.1
1.1
u/l
122.2
91.8
1.35
40
190
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
20
60
3.34
5.71
1.2
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
52
253
2.06
5.68
1.1
1.1
u/l
48.9
33.6
0.68
39
183
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
36
153
2.36
5.46
1.2
1.1
u/ml
1.1
10.6
—
9
12
(4268621)
68
369
1.85
5.45
2.2
2.3
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
106
653
1.63
5.45
1.2
1.2
miu/ml
132.3
210.9
1.34
27
234
(3036603) Volume of Urine
62
328
1.90
5.38
1.5
1.6
ml
1866.3
1810.8
0.08
13
94
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
29
112
2.60
5.37
1.1
1.3
%
100.3
93.0
0.43
29
101
(3044009) aPTT.lupus sensitive (LA screen)
13
30
4.34
5.29
1.5
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
48
930
0.51
5.22
1.4
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2472
22902
1.13
5.20
2.3
2.1
pmol/l
91.4
92.5
0.58
1440
12152
(3014148) Varicella zoster virus Ab [Titer] in Serum
63
340
1.86
5.16
1.2
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
22
75
2.94
5.13
1.1
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
187
1322
1.43
5.10
1.3
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
66
1154
0.57
5.09
1.7
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
185
1312
1.42
4.97
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
186
1328
1.41
4.82
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1226
13741
0.87
4.78
3.3
3.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
15
42
3.58
4.76
7.4
4.3
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
21
73
2.88
4.75
1.1
1.3
%
104.5
77.5
2.17
14
28
(3044889) 12 lead EKG panel
3651
34726
1.12
4.74
5.6
4.2
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
97
607
1.61
4.73
1.4
1.4
mu/l
105.7
57.9
1.00
84
536
(3002619) Bacteria identified in Specimen by Culture
24
92
2.61
4.55
1.3
1.2
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
27
110
2.46
4.53
1.1
1.2
%
82.8
82.0
0.06
20
61
(3045716) Anion gap in Serum or Plasma
50
262
1.92
4.52
2.1
2.1
mmol/l
7.9
9.6
3.45
39
201
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
34
154
2.21
4.51
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
17
54
3.15
4.48
1.5
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
134
914
1.48
4.46
1.1
1.1
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
31
136
2.29
4.44
1.9
1.8
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
23
88
2.62
4.38
1.5
1.6
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
47
244
1.93
4.38
1.7
1.4
%
1.3
4.4
2.31
19
56
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
83
511
1.63
4.36
1.1
1.1
%
109.3
114.1
0.50
78
450
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
85
531
1.61
4.22
1.4
1.3
nmol/l
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
10
23
4.35
4.08
1.3
1.3
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
20
74
2.71
4.08
1.1
1.3
%
72.3
80.0
0.42
12
27
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
71
428
1.67
4.07
2.3
1.9
u/l
6934.5
2477.4
0.53
32
161
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
8
10
8.01
4.06
1.5
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
13
37
3.52
4.04
1.3
1.3
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
35
169
2.08
4.00
4.5
5.4
%
64.9
71.5
0.54
28
134
(3019832) Treponema pallidum Ab [Presence] in Serum
217
1646
1.33
3.93
1.7
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
57
327
1.75
3.92
1.2
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
26
112
2.33
3.91
1.1
1.4
%
81.7
80.7
0.05
19
65
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
66
395
1.68
3.90
1.2
1.1
%
88.2
94.8
1.30
61
367
(3010144) Erythrocytes [#/volume] in Synovial fluid
83
529
1.58
3.83
1.7
1.3
e6/l
236563.0
158636.4
0.33
62
370
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
9
15
6.01
3.81
4.0
1.8
mg/l
1.2
2.5
—
9
9
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
11
29
3.80
3.80
1.1
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
118
815
1.46
3.75
1.6
1.3
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
99
660
1.51
3.74
4.8
4.3
umol/l
342.3
344.3
0.05
89
556
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
86
556
1.55
3.74
1.3
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
87
564
1.55
3.74
1.1
1.4
pmol/l
323.1
267.2
0.52
64
422
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
195
1476
1.33
3.61
2.8
2.3
ug/min
244.9
106.9
1.89
105
857
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
82
532
1.55
3.53
1.1
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
33
164
2.02
3.53
2.1
2.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
33
164
2.02
3.53
2.1
2.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
23
99
2.33
3.49
1.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
34
172
1.98
3.47
2.4
1.4
umol/l
27.5
29.3
0.31
34
166
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
25
113
2.22
3.40
1.2
1.3
%
122.8
111.8
1.06
20
96
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
7
10
7.01
3.36
1.1
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
7
10
7.01
3.36
1.0
1.0
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
105
728
1.45
3.31
2.5
2.1
mg/l
32.7
26.9
0.49
32
179
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
26
121
2.15
3.31
1.2
1.3
g/l
0.3
0.3
1.41
20
94
(3033705) Calcium.ionized [Moles/volume] in Venous blood
118
837
1.42
3.30
3.2
2.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
39
213
1.84
3.21
1.4
1.3
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
10
28
3.58
3.19
1.1
1.0
—
—
—
0
0
(3048879) Bone marrow aspiration report
33
171
1.93
3.18
1.6
1.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
63
395
1.60
3.18
1.1
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
27
130
2.08
3.17
2.8
2.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
39
214
1.83
3.16
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2342
24801
0.91
3.14
4.8
5.4
ug/l
2.9
3.9
2.48
2033
21999
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
90
613
1.47
3.13
1.4
1.3
nmol/l
0.1
0.3
—
7
44
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
39
216
1.81
3.08
1.4
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
24
112
2.15
3.05
1.1
1.2
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
6
8
7.51
3.05
1.0
1.1
g/l
0.2
0.2
—
6
8
(3011648) Oxygen content in Venous blood
64
408
1.57
3.03
2.5
2.1
%
9.7
10.9
1.42
64
408
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
37
203
1.83
3.02
3.3
2.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1294
14085
0.90
3.00
3.2
3.3
ug/l
0.7
0.8
2.19
959
10061
(3017704) Immunofixation for Urine
55
341
1.62
2.93
1.3
1.5
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
36
198
1.82
2.92
1.2
1.2
ratio
1.1
1.1
0.76
19
65
(3030313) Adrenal Ab [Titer] in Serum
8
17
4.71
2.91
1.1
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
21
95
2.21
2.89
1.1
1.2
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
17
70
2.43
2.87
1.4
1.2
ng/l
84.2
1365.8
—
10
47
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
12
41
2.93
2.85
1.7
1.3
ml/s/173m2
1.0
1.0
—
7
22
(3002385) Erythrocyte distribution width [Ratio]
3909
37791
1.09
2.81
42.9
20.0
%
14.7
13.9
169.86
3834
36856
(40761539) Cells [Type] in Urine sediment by Light microscopy
27
137
1.97
2.79
1.4
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
14
53
2.65
2.79
1.1
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
339
4025
0.83
2.73
1.3
1.4
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
6
10
6.01
2.69
7.3
6.5
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
6
10
6.01
2.69
1.0
1.0
u/field
1.3
1.3
—
6
10
(3032352) Blasts [#/volume] in Cerebral spinal fluid
11
37
2.98
2.69
2.3
1.6
—
—
—
0
0
(4306422)
77
528
1.46
2.65
1.2
1.2
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
10
32
3.13
2.64
1.2
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
268
2204
1.23
2.64
1.2
1.2
iu/ml
86.5
130.7
2.00
91
760
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
13
49
2.66
2.62
1.6
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
13
49
2.66
2.62
1.6
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
13
49
2.66
2.62
1.6
1.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
15
61
2.46
2.61
1.0
1.1
%
59.4
49.7
—
5
23
(40765096) Chromosome analysis panel by Banding
32
177
1.81
2.59
1.1
1.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
5
7
7.15
2.55
1.0
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
18
81
2.23
2.53
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
51
783
0.65
2.49
1.4
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
525
4603
1.15
2.49
4.6
3.5
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
57
2.46
2.44
3.6
4.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
154
1201
1.29
2.42
1.7
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
216
1755
1.24
2.41
1.3
1.3
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
10
34
2.94
2.41
1.1
1.1
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
18
83
2.17
2.40
1.2
1.2
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
6
12
5.00
2.40
1.0
1.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
21
402
0.52
2.40
1.0
1.0
ng/l
47.9
45.5
0.13
14
252
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
9
27
3.34
2.39
5.1
3.8
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
21
401
0.52
2.38
1.0
1.0
ng/l
321.4
327.2
0.05
14
258
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
21
401
0.52
2.38
1.0
1.0
ng/l
575.6
685.5
0.71
13
254
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
8
6.25
2.37
1.6
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
68
469
1.45
2.31
1.4
1.6
u/ml
18.5
24.8
0.49
13
98
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
17
78
2.18
2.30
1.0
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
10
35
2.86
2.30
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
23
119
1.94
2.29
1.3
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
11
41
2.69
2.27
1.1
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
35
208
1.69
2.26
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
39
240
1.63
2.21
1.4
1.2
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
5
9
5.56
2.21
1.8
2.0
—
—
—
0
0
(4034850)
125
1609
0.77
2.18
14.7
11.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1872
17695
1.08
2.18
4.4
4.0
mg/mmol
22.8
9.4
9.79
1252
11317
(40768443) Skin Pathology biopsy report
266
2236
1.20
2.15
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
4217
41100
1.08
2.13
35.1
17.9
%
37.2
38.9
21.01
2503
26128
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
34
205
1.66
2.10
1.4
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
43
2.56
2.09
1.0
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
5
10
5.00
2.07
1.4
1.3
mg/l
21.7
115.0
—
5
10
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
10
5.00
2.07
1.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
5
10
5.00
2.07
1.8
1.1
nmol/l
874.4
347.6
—
5
10
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
32
191
1.68
2.06
3.4
2.6
—
33.2
—
0
5
(3027974) Hepatitis B virus e Ag [Presence] in Serum
7
20
3.50
2.05
3.9
1.4
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
15
69
2.18
2.04
1.5
1.6
pmol/l
33.8
43.5
—
9
53
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
15
4.00
2.04
1.0
1.0
%
2.8
3.1
—
6
15
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
38
238
1.60
2.03
1.4
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
22
119
1.85
1.96
1.5
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
21
3.34
1.96
1.1
1.0
—
—
—
0
0
(1002224) Polysomnography panel
101
1314
0.76
1.95
1.1
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
12
51
2.36
1.94
1.6
1.5
umol/l
49.2
43.5
0.30
12
51
(3011325) HIV 1+2 Ab [Presence] in Serum
5
11
4.55
1.94
1.0
1.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1239
11569
1.09
1.93
4.6
3.8
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
11
45
2.45
1.92
1.1
1.1
u/l
6.9
9.9
0.80
11
45
(3009508) Creatinine [Moles/volume] in Urine
1798
17043
1.08
1.92
3.5
3.2
mmol/l
7.0
7.5
5.85
1464
14028
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
39
250
1.56
1.91
1.4
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
23
128
1.80
1.89
1.0
1.1
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
32
197
1.63
1.86
1.3
1.2
g/l
40.0
40.1
0.01
17
104
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
23
129
1.79
1.85
2.1
2.3
mmol/l
7.9
8.0
0.07
14
82
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
390
4416
0.88
1.80
1.6
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
73
2.06
1.80
1.2
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
7
23
3.05
1.80
1.3
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
5079
49972
1.08
1.78
40.9
19.5
mmol/l
138.6
139.6
110.60
4968
48599
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
11
47
2.34
1.77
3.3
3.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
61
438
1.40
1.74
1.3
1.4
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
12
54
2.22
1.73
3.3
1.7
mmol/l
1.9
2.8
0.99
12
48
(3020191) Ethanol [Moles/volume] in Serum or Plasma
47
322
1.46
1.73
1.3
1.3
promille
1.4
1.2
0.48
34
249
(3029075) Extractable nuclear Ab panel - Serum
20
110
1.82
1.72
1.1
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
8
30
2.67
1.72
1.1
1.1
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
7
24
2.92
1.72
3.9
1.3
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
19
103
1.85
1.71
1.2
1.2
mg/l
1.0
95.8
0.80
14
78
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
151
1839
0.82
1.70
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1759
16734
1.07
1.68
3.5
3.3
mg/l
508.0
347.9
0.80
1207
10837
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
343
3013
1.15
1.67
2.5
2.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
5085
50071
1.08
1.66
41.2
19.7
mmol/l
4.0
4.0
12.58
4963
48616
(3038071) Oxygen [Partial pressure] in Mixed venous blood
21
119
1.77
1.65
10.1
8.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
14
69
2.03
1.64
2.4
2.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
20
112
1.79
1.64
1.0
1.1
pmol/l
267.8
232.8
0.27
13
79
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
87
1123
0.77
1.63
1.7
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
132
1619
0.81
1.61
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
29
182
1.60
1.59
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
14
70
2.00
1.59
1.2
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
22
129
1.71
1.56
1.2
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
23
137
1.68
1.54
1.2
1.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
13
64
2.03
1.54
1.2
1.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
14
72
1.95
1.48
1.6
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
17
94
1.81
1.47
8.5
7.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
302
3423
0.88
1.47
3.5
3.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
42
293
1.44
1.45
1.9
1.9
u/field
5.0
2.5
0.33
29
203
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
7
28
2.50
1.45
9.1
9.7
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
46
637
0.72
1.43
1.3
1.4
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
25
157
1.59
1.40
2.8
1.8
ug/l
23.0
69.8
0.47
25
143
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
16
89
1.80
1.37
1.0
1.1
—
5.0
—
0
14
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
42
2.14
1.33
1.2
1.1
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
30
200
1.50
1.32
1.0
1.1
iu/ml
5.8
12.6
—
6
56
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
906
8498
1.08
1.29
1.3
1.2
u/ml
1.3
1.8
1.34
215
2130
(3019150) Specific gravity of Urine by Refractometry
1017
10786
0.93
1.29
5.6
4.3
kg/l
1.0
1.0
1.74
163
1639
(44816559) Phosphatidylethanol [Mass/volume] in Blood
85
676
1.26
1.28
1.8
1.3
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
13
69
1.89
1.28
2.5
2.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
131
0.46
1.28
1.0
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3534
34537
1.05
1.26
4.3
3.7
pmol/l
15.3
15.0
7.21
3151
30662
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4518
44454
1.06
1.23
33.5
15.7
ml/min/173m2
71.7
74.1
8.52
4063
36801
(3024869) Neuronal Ab [Presence] in Serum
17
100
1.70
1.23
1.2
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
63
1.91
1.22
2.3
1.7
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
10
49
2.04
1.22
1.6
1.5
%
0.5
0.9
—
5
34
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
22
140
1.57
1.19
10.5
8.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
213
0.56
1.19
1.3
1.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
47
349
1.35
1.18
3.7
2.4
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
8
38
2.11
1.18
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
170
0.53
1.18
1.3
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
12
64
1.88
1.18
3.0
1.1
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
26
173
1.50
1.17
2.0
2.7
umol/l
28.8
29.3
0.07
13
129
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
17
102
1.67
1.16
1.2
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
20
2.50
1.15
1.0
1.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
103
850
1.22
1.14
1.8
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
503
4633
1.09
1.14
2.0
2.1
ug/g
220.8
160.7
1.50
407
3596
(3014051) Protein [Presence] in Urine by Test strip
98
1185
0.82
1.12
2.9
2.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
113
0.44
1.12
1.0
1.5
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
7
30
2.33
1.12
1.1
1.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
41
302
1.36
1.10
2.2
1.9
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
39
285
1.37
1.10
1.9
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
27
388
0.69
1.10
1.6
1.6
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
366
4019
0.91
1.09
2.2
2.1
nmol/l
10.5
12.0
2.46
319
3465
(3051593) INR in Capillary blood by Coagulation assay
44
329
1.34
1.08
8.1
13.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
165
0.54
1.07
1.3
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
227
1.41
1.07
1.2
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
166
0.54
1.07
1.3
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
40
296
1.35
1.05
1.8
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
31
220
1.41
1.04
1.5
1.7
umol/l
27.8
10.2
0.90
24
141
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
46
1.96
1.03
1.1
1.5
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
34
2.06
1.02
1.0
1.1
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
26
180
1.45
1.00
1.0
1.1
ng/l
131.3
675.3
—
7
45
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
177
1553
1.14
0.99
1.1
1.1
u/ml
1.2
1.3
—
6
25
(3025018) Bordetella pertussis Ab [Titer] in Serum
26
181
1.44
0.98
1.1
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
15
92
1.63
0.97
1.1
1.1
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
20
132
1.52
0.96
1.7
1.3
%
34.8
33.8
0.05
15
88
(3001729) Color of Synovial fluid
10
54
1.85
0.96
1.6
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
36
267
1.35
0.95
2.4
2.2
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
26
182
1.43
0.95
1.7
1.3
%
62.2
62.0
0.01
21
153
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
27
2.22
0.93
1.0
1.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
52
1.73
0.92
1.1
1.1
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
6
28
2.14
0.91
1.7
1.3
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
11
63
1.75
0.90
1.4
1.2
mmol/l
5.2
6.8
—
6
26
(4024509)
41
530
0.77
0.89
2.1
1.5
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
6
29
2.07
0.89
1.7
1.4
pmol/l
14.5
25.8
—
6
22
(3045683) HLA typing for celiac disease panel - Blood or Tissue
25
177
1.41
0.88
1.0
1.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
48
377
1.28
0.87
2.7
2.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
205
0.63
0.87
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
205
0.63
0.87
1.3
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
229
0.65
0.87
1.5
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
31
229
1.36
0.86
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
204
0.64
0.85
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
204
0.64
0.85
1.3
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
4893
48407
1.05
0.85
32.3
15.8
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
77
643
1.20
0.82
2.1
1.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
61
498
1.23
0.82
2.1
2.1
u/field
2.0
1.8
0.10
25
173
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
6
32
1.88
0.81
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
268
2935
0.91
0.81
4.6
3.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
8
48
1.67
0.78
2.1
2.0
umol/l
14.3
17.6
—
8
48
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
8
48
1.67
0.78
1.1
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
17
115
1.48
0.76
1.6
1.5
ug/l
11.4
9.2
0.93
17
115
(3000034) Microalbumin [Mass/volume] in Urine
63
521
1.21
0.76
2.9
3.2
mg/l
132.9
45.4
0.89
50
399
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
11
67
1.64
0.75
1.3
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
38
480
0.79
0.73
1.3
1.2
mmol/l
8.3
7.5
0.58
27
340
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
76
1.58
0.71
1.8
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
21
287
0.73
0.71
1.0
1.1
u/ml
10.8
2.1
—
5
111
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
41
1.71
0.70
1.0
1.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
5
27
1.85
0.68
2.4
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
31
240
1.29
0.67
1.2
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
43
1.63
0.66
1.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
7
43
1.63
0.66
1.0
1.0
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
85
982
0.86
0.66
1.1
1.1
u/ml
9.8
8.8
—
10
81
(3008898) HLA-B27 [Presence]
86
991
0.87
0.65
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
67
569
1.18
0.64
1.3
1.3
—
—
—
0
0
(4133840)
15
104
1.44
0.62
1.1
1.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4233
42788
0.97
0.61
5.2
4.6
mu/l
2.4
2.1
0.58
3801
38229
(3010813) Leukocytes [#/volume] in Blood
5126
51639
0.96
0.61
51.4
24.2
e9/l
7.5
6.9
30.24
4980
49786
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
8
51
1.57
0.60
1.1
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
5126
51634
0.96
0.59
51.6
24.3
g/l
125.6
134.1
229.92
5035
50623
(3027008) Opiates [Presence] in Urine
68
583
1.17
0.59
2.2
1.8
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
622
6511
0.95
0.59
4.5
4.8
%
33.5
32.9
0.52
439
4238
(3016018) Differential panel - Cerebral spinal fluid
51
427
1.20
0.58
1.2
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
16
114
1.40
0.58
1.3
1.3
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
8
53
1.51
0.58
1.5
1.3
—
208.8
—
0
8
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
166
1512
1.10
0.58
1.6
1.6
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
13
89
1.46
0.58
1.0
1.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
5126
51624
0.96
0.57
51.2
24.1
e12/l
4.2
4.4
139.71
4970
49776
(3035941) MCH [Entitic mass]
5126
51622
0.96
0.57
51.0
24.0
pg
30.3
30.5
13.92
5034
50606
(3024731) MCV [Entitic volume]
5126
51621
0.96
0.57
51.1
24.1
fl
92.1
91.7
6.84
5036
50605
(3013139) Helicobacter pylori Ag [Presence] in Stool
277
2966
0.93
0.55
1.2
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
5126
51613
0.96
0.55
51.2
24.1
e9/l
249.9
238.3
19.98
4997
49972
(3020491) Glucose [Moles/volume] in Blood
44
366
1.20
0.55
1.7
2.1
mmol/l
6.9
7.0
0.12
31
238
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
14
99
1.42
0.54
1.0
1.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
91
806
1.13
0.53
1.5
1.4
iu/l
29.2
30.2
0.12
77
684
(3026389) Candida sp identified in Specimen by Organism specific culture
67
581
1.15
0.53
1.2
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
18
134
1.34
0.53
1.2
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
654
6814
0.96
0.53
14.2
8.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
13
92
1.41
0.50
1.2
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
18
136
1.32
0.49
1.1
1.1
miu/ml
1668.2
1591.3
0.12
18
136
(3025130) Human papilloma virus identified in Specimen
20
257
0.78
0.49
1.9
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
67
586
1.14
0.48
2.3
1.8
—
—
—
0
0
(4198724)
13
93
1.40
0.48
1.4
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
15
200
0.75
0.47
1.0
1.2
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
7
47
1.49
0.47
1.1
1.3
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
37
441
0.84
0.47
1.1
1.1
u/ml
9.8
2.6
0.54
12
145
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
7
48
1.46
0.46
1.1
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
47
402
1.17
0.46
1.1
1.1
—
29.1
—
0
7
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
39
329
1.19
0.44
5.7
5.1
u/ml
244.7
41.3
0.56
14
94
(3015076) Soybean IgE Ab [Units/volume] in Serum
12
86
1.40
0.44
1.0
1.1
—
8.2
—
0
10
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
30
247
1.22
0.44
1.1
1.1
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
5
32
1.56
0.42
1.6
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
51
585
0.87
0.42
1.6
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
65
575
1.13
0.42
2.2
1.8
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
57
1.40
0.42
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
70
1.43
0.41
2.7
2.7
u/field
0.7
0.3
—
10
70
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
150
0.73
0.41
1.2
1.7
—
—
—
0
0
(3027874) Urate [Moles/volume] in Urine
0
15
0.00
0.41
0.0
1.1
—
1.9
—
0
10
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
1.4
—
0
16
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
49
426
1.15
0.40
1.1
1.1
—
3.3
—
0
7
(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.1
—
175.1
—
0
12
(3023511) Choriogonadotropin [Units/volume] in Urine
23
186
1.24
0.40
1.4
1.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
65
578
1.13
0.39
2.3
1.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
96
874
1.10
0.39
1.3
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
41
354
1.16
0.38
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
27
323
0.84
0.38
1.0
1.2
mmol/l
12.4
12.0
—
10
100
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
31
263
1.18
0.35
1.1
1.1
mg/l
272.2
304.6
0.47
24
224
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
24
199
1.21
0.35
1.9
2.2
umol/l
57.1
57.1
0.00
17
160
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
13
100
1.30
0.33
2.8
3.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
151
1611
0.94
0.33
1.6
1.7
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
27
228
1.19
0.33
1.1
1.2
nmol/l
122.4
139.2
1.72
27
228
(3045414) Leukocytes [Presence] in Urine
214
2257
0.95
0.33
2.3
2.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
166
0.78
0.33
1.2
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
46
1.30
0.33
1.5
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
46
407
1.13
0.32
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
46
407
1.13
0.32
1.3
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
119
1.26
0.31
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
39
443
0.88
0.31
1.1
1.1
u/ml
0.4
2.5
2.52
15
175
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
7
55
1.27
0.30
2.3
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
68
743
0.91
0.28
1.6
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
8
62
1.29
0.28
1.1
1.3
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
12
95
1.26
0.26
1.5
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
59
539
1.10
0.26
2.4
1.9
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
5
75
0.67
0.25
1.6
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
50
453
1.10
0.25
2.1
1.8
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
27
235
1.15
0.25
7.5
6.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
78
1.28
0.24
2.0
1.4
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
514
5011
1.03
0.23
1.4
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
74
688
1.08
0.23
1.1
1.1
iu/ml
150.2
1193.6
0.59
18
140
(3006462) Nitrate [Presence] in Urine
28
248
1.13
0.21
4.0
3.9
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.5
—
1.9
—
0
11
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
2.4
—
2.6
—
0
10
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
49
1.22
0.20
1.7
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
18
155
1.16
0.19
1.1
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
31
279
1.11
0.19
1.2
1.1
mg/l
41.9
44.4
0.12
23
229
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
118
1.19
0.19
1.2
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
24
270
0.89
0.19
1.2
1.1
nmol/l
2.6
8.4
—
8
64
(3034092) Cytoplasmic Ig cells/100 cells in Blood
6
53
1.13
0.18
27.5
11.9
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
15
128
1.17
0.18
1.2
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
12
100
1.20
0.18
1.2
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
30
271
1.11
0.18
1.3
1.3
nmol/l
1.2
1.1
0.05
20
202
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
33
300
1.10
0.17
1.2
1.5
nmol/l
0.2
0.2
0.23
23
232
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
248
2555
0.97
0.17
1.4
1.3
au/ml
34.7
60.6
1.70
13
108
(3025577) Chromium [Mass/volume] in Blood
43
397
1.08
0.17
1.7
2.0
ug/l
1.5
2.1
2.02
32
326
(1761482) Bacteria [#/volume] in Urine by Culture
172
1659
1.04
0.17
4.8
4.4
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
175
1690
1.04
0.16
1.1
1.1
titre
14.0
240.0
—
5
39
(3020650) Glucose [Presence] in Urine
12
101
1.19
0.16
1.4
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
173
1791
0.96
0.16
1.6
1.7
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
60
564
1.06
0.16
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
214
0.89
0.15
1.2
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
296
3030
0.98
0.14
1.2
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
22
198
1.11
0.14
1.0
1.1
u/l
1.1
1.2
0.43
15
101
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
114
1099
1.04
0.13
1.4
1.3
mg/l
529.4
576.6
0.47
109
1024
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
85
1.18
0.12
2.8
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
204
2091
0.97
0.12
1.3
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
14
158
0.89
0.12
1.4
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
99
954
1.04
0.12
1.4
1.3
e6/l
9.2
25.0
1.14
78
737
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
99
954
1.04
0.12
1.5
1.4
e6/l
395.3
890.2
1.18
83
776
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
30
323
0.93
0.11
2.0
2.2
ug/min
107.3
201.6
—
8
82
(44813793)
25
230
1.09
0.11
1.0
1.0
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
16
178
0.90
0.11
1.7
1.7
nmol/l
5.3
7.4
0.21
16
152
(4094501)
126
1298
0.97
0.11
1.1
1.1
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
83
799
1.04
0.11
1.4
1.7
mu/l
386.6
306.8
0.64
77
736
(1617658) Protocol used for examination of sentinel lymph nodes
30
280
1.07
0.10
1.1
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
12
106
1.13
0.09
1.1
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
36
381
0.94
0.09
1.0
1.1
u/ml
3.4
3.9
0.05
16
182
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
14
155
0.90
0.09
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
35
370
0.95
0.09
1.0
1.1
u/ml
0.5
1.7
1.36
11
158
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
54
1.11
0.09
1.2
1.0
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
27
288
0.94
0.08
1.3
1.4
pmol/l
97.1
157.4
—
10
91
(3015183) Erythrocyte sedimentation rate
13
144
0.90
0.08
1.0
1.2
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
5
62
0.81
0.08
1.2
5.1
mmol/l
7.4
8.3
—
5
35
(4211845)
29
273
1.06
0.08
4.3
3.7
—
—
—
0
0
(4212803)
7
64
1.09
0.08
1.1
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
280
2840
0.99
0.07
2.6
2.4
au/ml
31.5
25.3
—
8
97
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
133
0.90
0.07
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5008
50023
1.01
0.06
19.9
10.8
u/l
25.1
25.8
0.86
4880
47778
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
119
1.09
0.06
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
81
791
1.02
0.05
1.3
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
19
202
0.94
0.05
1.4
1.4
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
32
307
1.04
0.05
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
14
130
1.08
0.04
1.2
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
49
504
0.97
0.04
1.3
1.2
nmol/l
333.4
335.5
0.02
41
395
(3037556) Urate [Mass/volume] in Serum or Plasma
17
180
0.94
0.04
1.9
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
13
121
1.07
0.03
1.2
1.1
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
121
1194
1.01
0.03
3.3
3.7
mg/l
35.4
30.6
0.57
89
781
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
99
976
1.01
0.03
2.1
1.5
nmol/l
0.8
0.8
0.02
72
801
(4146454)
65
639
1.02
0.02
3.0
2.8
—
—
—
0
0
(44806420)
22
212
1.04
0.02
1.9
2.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
14
146
0.96
0.00
2.4
1.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
42
414
1.01
0.00
1.7
1.9
ug/l
2.6
3.6
0.94
36
352
(3051101) Glucose [Moles/volume] in Cord blood
12
122
0.98
0.00
3.7
6.3
—
—
—
0
0
(4027681)
20
198
1.01
0.00
1.4
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
12
116
1.03
0.00
1.2
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
186
1.02
0.00
1.2
1.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
27
266
1.02
0.00
1.8
1.7
nmol/l
16.9
16.1
0.23
22
247
(3023410) Appearance of Cerebral spinal fluid
40
401
1.00
0.00
1.5
1.5
—
—
—
0
0
(3021374) Sirolimus [Mass/volume] in Blood
0
5
0.00
0.00
0.0
7.0
—
7.2
—
0
5
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.2
—
0.3
—
0
5
(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count
0
5
0.00
0.00
0.0
5.8
—
14.0
—
0
5
(3028717) Thiamine [Mass/volume] in Blood
5
54
0.93
0.00
1.0
1.2
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
96
0.94
0.00
1.8
1.6
ng/l
135.2
155.8
—
9
96
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
1.3
—
0
6
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.2
—
1.3
—
0
6
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
545
5450
1.00
0.00
1.3
1.3
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
8
87
0.92
0.00
1.1
1.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043614) Bacteria identified in Aspirate by Culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint J10_PLEUREFFUSION and mortality.

Females

Parameter HR [95% CI] p-value
J10_PLEUREFFUSION 4.638 [4.08, 5.27] < 0.001
Birth year 0.997 [0.99, 1.01] 0.508

During the follow-up period (1.1.1998 — 31.12.2019), 9071 out of 14473 females with J10_PLEUREFFUSION died.

Males

Parameter HR [95% CI] p-value
J10_PLEUREFFUSION 3.657 [3.22, 4.15] < 0.001
Birth year 0.99 [0.98, 1.0] 0.021

During the follow-up period (1.1.1998 — 31.12.2019), 13181 out of 21590 males with J10_PLEUREFFUSION died.

Mortality risk

Mortality risk for people of age

years, who have J10_PLEUREFFUSION.

N-year risk Females Males
1 0.516% 0.574%
5 2.675% 3.896%
10 6.238% 9.99%
15 13.027% 18.751%
20 21.6% 29.907%

Relationships between endpoints

Index endpoint: J10_PLEUREFFUSION – Pleural effusion

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data